Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Ribosome,0.5333449808388002,2.637740303365548,0.0,0.0,0.0,79/158,31.23%,RPS20;RPL7;RPL19;RPS8;RPS5;RPL8;RPS3;RPL4;RPS3A;MRPS7;RPL17;RPS23;MRPS11;RPL41;RPS21;RPS18;MRPL11;RPL30;MRPS5;RPL3;RPL6;RPS4X;MRPL24;RPL18;RPL18A;RPL10;RPS19;RPS28;RPL32;FAU;RPS13;RPS27A;RPL37;RPL5;RPLP0;MRPS18A;RPLP1;MRPL4;RPL28;RPS2;RPL24;RPS17;RPS24;RPS6;RPL13;RPS11;RPL12;RPL37A;RPL10A;RPL11;MRPL34;RPL13A;RPL23;RPL35;RPL34;RPS16;MRPL10;RPL36;RPL29;RPL26;RPL31;RPL22;RPL22L1;RPLP2;RPL23A;MRPL28;RPL38;MRPS21;RPL15;RPL27A;MRPS2;RPS25;RPL35A;MRPL23;RPL7A;MRPS15;RPS12;MRPL13;UBA52
prerank,Coronavirus disease,0.5242302593010039,2.603490787601393,0.0,0.0,0.0,84/232,28.16%,RPS20;CFD;RPL7;RPL19;RPS8;MAPK1;RPS5;RPL8;RPS3;PLCG1;RPL4;TYK2;RPS3A;MAPK3;RPL17;RPS23;RPL41;RPS21;RPS18;RPL30;EIF2AK2;STAT1;RPL3;RPL6;RPS4X;RPL18;RPL18A;PRKCA;RPL10;RPS19;RPS28;RPL32;FAU;IRF3;RPS13;RPS27A;EGFR;RPL37;RPL5;RPLP0;RPLP1;RPL28;RPS2;IL6ST;RPL24;RPS17;TAB2;PIK3CB;PRKCG;TNFRSF1A;RPS24;RPS6;RPL13;PIK3CA;RPS11;RPL12;RPL37A;IFNAR1;C3;MAP3K7;RPL10A;RPL11;C1S;MAPK8;RPL13A;RPL23;RPL35;RPL34;RPS16;RPL36;RPL29;RPL26;RPL31;PIK3R3;RPL22;RPL22L1;RPLP2;RPL23A;MAPK11;IKBKG;RPL38;RPL15;RPL27A;RPS25
prerank,Focal adhesion,0.4691649699208537,2.272370235481957,0.0,0.0,0.0,66/201,25.16%,ITGA3;VCL;LAMA5;PAK2;AKT3;FLNA;LAMB1;SHC3;VEGFA;PPP1R12C;PPP1CA;ACTG1;ROCK1;ACTN4;FLNB;MAPK1;MET;MYL12B;DIAPH1;SPP1;PPP1R12A;MAPK3;BIRC2;FLNC;CDC42;PAK1;THBS1;COL4A5;GSK3B;PRKCA;AKT1;BIRC3;RAP1B;RAC1;EGFR;PIK3CB;PRKCG;CTNNB1;COL6A1;RAP1A;PIK3CA;ACTB;LAMC2;LAMB2;COL6A2;ARHGAP35;GRB2;PXN;VEGFC;MAPK8;IGF1R;CAV1;MYL12A;BAD;CRK;SHC1;MYL5;SOS1;AKT2;CAPN2;PIK3R3;LAMA4;FN1;ITGB4;CCND1;ROCK2
prerank,Salivary secretion,0.6682424734275546,2.2644879350996705,0.0,0.0,0.0,20/93,22.01%,CALML5;GNAS;PRKACB;SLC9A1;ITPR3;SLC4A2;ATP2B1;ATP2B4;PRKCA;CALM2;ADCY6;PRKCG;CST3;PRKACA;CALM1;CALM3;ADCY7;VAMP2;KCNN4;ATP1A1
prerank,Gastric acid secretion,0.6958207606641706,2.256398187637297,0.0,0.0,0.0,19/76,19.17%,CALML5;ACTG1;GNAS;PRKACB;EZR;SLC9A1;ITPR3;SLC4A2;PRKCA;GNAI2;CA2;CALM2;ADCY6;PRKCG;PRKACA;ACTB;CALM1;CALM3;ADCY7
prerank,Thyroid hormone signaling pathway,0.5240975711991889,2.2445229457000146,0.0,0.0,0.0,40/121,23.53%,RXRA;AKT3;SLC2A1;TP53;ACTG1;NOTCH2;MTOR;HDAC2;MAPK1;PFKP;PLCG1;PRKACB;SLC9A1;MED13;MAPK3;MED4;STAT1;GSK3B;NCOR1;PRKCA;AKT1;HDAC1;KRAS;MED17;PIK3CB;PRKCG;CTNNB1;MED1;MYC;PIK3CA;PRKACA;ACTB;NRAS;MED14;EP300;BAD;ATP1A1;AKT2;RHEB;PIK3R3
prerank,Vibrio cholerae infection,0.6013098365191833,2.201956545312302,0.0,0.0,0.0,18/50,17.70%,KDELR1;KDELR2;ACTG1;ATP6V0C;PLCG1;GNAS;PRKACB;ARF1;ATP6V1F;PRKCA;PDIA4;ATP6V0A1;ATP6AP1;PRKACA;ACTB;ERO1A;TJP2;TCIRG1
prerank,DNA replication,-0.5759709472336787,-2.1972969862491554,0.0,0.0,0.0,21/36,28.24%,MCM2;MCM6;PCNA;FEN1;DNA2;POLE;MCM3;PRIM2;POLD1;RFC5;PRIM1;POLE2;MCM5;POLD3;RFC2;RNASEH2A;POLA1;RFC3;RFC4;MCM7;POLE3
prerank,Pancreatic secretion,0.6073575353582235,2.1806964708479524,0.0,0.0,0.0,17/102,22.01%,RAB11A;GNAS;SLC9A1;ITPR3;SLC4A2;ATP2B1;ATP2B4;PRKCA;RAP1B;RAC1;CA2;ADCY6;PRKCG;RAP1A;RAB3D;ADCY7;ATP1A1
prerank,Insulin signaling pathway,0.4951887821500225,2.17925147574216,0.0,0.0,0.0,49/137,23.53%,PRKCI;AKT3;PYGL;SHC3;CALML5;PPP1CA;MTOR;MAPK1;CBL;PRKAR1B;PRKAA1;PTPRF;PRKACB;MAPK3;RPS6KB1;PHKB;GSK3B;INPPL1;MKNK2;PRKAR1A;AKT1;RPTOR;PRKAB1;RHOQ;HK1;PRKCZ;KRAS;EIF4E2;CALM2;MKNK1;PIK3CB;RPS6;PRKAR2A;PIK3CA;PRKACA;NRAS;CALM1;GYS1;CALM3;FASN;GRB2;MAPK8;BAD;CRK;SHC1;SOS1;AKT2;RHEB;PIK3R3
prerank,Proteoglycans in cancer,0.44485225795709143,2.130035857799331,0.0,0.0,0.0,69/205,27.11%,PTCH1;AKT3;CTTN;FLNA;VEGFA;PPP1R12C;TP53;PPP1CA;ACTG1;MTOR;ROCK1;FLNB;MAPK1;CBL;MET;PLCG1;PRKACB;PPP1R12A;EZR;SLC9A1;MAPK3;ITPR3;RPS6KB1;FLNC;CDC42;PAK1;THBS1;DDX5;PRKCA;AKT1;RAC1;EGFR;EIF4B;KRAS;ERBB3;PIK3CB;PRKCG;CTNNB1;MYC;RPS6;PIK3CA;PRKACA;ACTB;NRAS;WNT9A;GRB2;PXN;RRAS2;CD44;GPC1;IGF1R;CAV1;SMAD2;CDKN1A;SOS1;AKT2;PIK3R3;FN1;SDC1;MSN;CCND1;PLAUR;ROCK2;RDX;MAPK11;PTK2;ARHGEF12;HSPG2;PDPK1
prerank,Adherens junction,0.5071461804452952,2.114229085340663,0.0,0.0,0.0,28/71,21.77%,VCL;SMAD3;WASL;ACTG1;ACTN4;MAPK1;MET;TGFBR2;PTPRF;MAPK3;CSNK2A2;CDC42;PTPRJ;WASF2;RAC1;PTPRB;EGFR;CTNNB1;YES1;NECTIN1;ACTB;LMO7;AFDN;MAP3K7;EP300;IGF1R;CTNND1;CSNK2A1
prerank,Bacterial invasion of epithelial cells,0.49956576833371874,2.1092544106320736,0.0,0.0,0.0,34/77,27.03%,VCL;CLTB;WASL;CTTN;SHC3;ACTG1;CBL;MET;CD2AP;CDC42;WASF2;RAC1;ARPC1B;DNM2;ARPC3;PIK3CB;CTNNB1;CLTC;PIK3CA;ACTB;DNM1;PXN;CAV1;CRK;SHC1;ACTR3C;PIK3R3;ARPC5;FN1;ACTR2;RHOG;CTNNA1;PTK2;CRKL
prerank,Glioma,0.5333691782221037,2.097732270970581,0.0,0.0,0.0,32/75,25.67%,CDK6;AKT3;SHC3;CALML5;TP53;MTOR;MAPK1;PLCG1;MAPK3;RB1;PRKCA;AKT1;BAX;EGFR;KRAS;CDKN2A;CALM2;PIK3CB;PRKCG;PIK3CA;NRAS;CALM1;CALM3;GRB2;IGF1R;SHC1;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;GADD45A
prerank,Apelin signaling pathway,0.4901906124737703,2.091402829195404,0.0,0.0,0.0,37/137,22.99%,SMAD3;AKT3;CALML5;GNB1;MTOR;MAPK1;PRKAA1;SPP1;GNG5;PRKACB;SLC9A1;MAPK3;ITPR3;RPS6KB1;PIK3C3;AKT1;GNB5;GNAI2;PRKAB1;GABARAP;BECN1;KRAS;CALM2;ADCY6;RPS6;PRKACA;NRAS;CALM1;CALM3;GNG12;GNA13;ADCY7;RRAS2;CCN2;SMAD2;GNB2;AKT2
prerank,Adrenergic signaling in cardiomyocytes,0.4913375759835016,2.0883185912453164,0.0,0.0,0.0,29/150,19.17%,PPP2R5E;ATF4;AKT3;CALML5;PPP1CA;PPP2R1A;MAPK1;GNAS;PRKACB;SLC9A1;MAPK3;CREB3L2;ATP2B1;TPM1;ATP2B4;PRKCA;AKT1;CACNG6;GNAI2;TPM3;CALM2;ADCY6;TPM4;PRKACA;CALM1;CALM3;CREB3;TPM2;ADCY7
prerank,Circadian entrainment,0.5979760467538217,2.055161268313365,0.0,0.0,0.0,19/97,19.17%,CALML5;GNB1;MAPK1;GNAS;GNG5;PRKACB;MAPK3;ITPR3;PRKCA;GNB5;GNAI2;CALM2;ADCY6;PRKCG;PRKACA;CALM1;CALM3;GNG12;ADCY7
prerank,ErbB signaling pathway,0.49571654892113415,2.0451723265688964,0.0,0.0,0.0,34/85,23.53%,ABL2;PAK2;AKT3;SHC3;MTOR;MAPK1;CBL;PLCG1;MAPK3;RPS6KB1;PAK1;GSK3B;NRG4;PRKCA;AKT1;EGFR;KRAS;ERBB3;PIK3CB;PRKCG;MYC;PIK3CA;NCK1;NRAS;MAP2K4;GRB2;MAPK8;BAD;CRK;SHC1;CDKN1A;SOS1;AKT2;PIK3R3
prerank,Estrogen signaling pathway,0.4958363370643703,2.044656416690611,0.0,0.0,0.0,36/137,23.53%,ATF4;KRT17;AKT3;SHC3;CALML5;FKBP4;MAPK1;SP1;GNAS;PRKACB;MAPK3;ITPR3;KRT13;CREB3L2;CTSD;AKT1;GNAI2;EGFR;KRAS;CALM2;ADCY6;PIK3CB;HSP90B1;PIK3CA;PRKACA;NRAS;CALM1;CALM3;CREB3;GRB2;ADCY7;KRT19;SHC1;SOS1;AKT2;PIK3R3
prerank,Vascular smooth muscle contraction,0.5070192923287804,2.042971871443183,0.0,0.0,0.0,23/133,19.17%,CALML5;PPP1R12C;GNA12;PPP1CA;ROCK1;MYH9;MAPK1;GNAS;MYH14;PRKACB;PPP1R12A;MAPK3;ITPR3;CALD1;PRKCA;CALM2;ADCY6;PRKCG;PRKACA;CALM1;CALM3;GNA13;ADCY7
prerank,Bile secretion,0.5581571548055803,2.042289329072374,0.0,0.0,0.0,16/90,22.01%,RXRA;SLC2A1;GNAS;PRKACB;SLC9A1;SLC4A2;SCARB1;SLCO1B3;UGT1A6;ABCC3;CA2;ADCY6;PRKACA;UGT1A3;ADCY7;ATP1A1
prerank,Hedgehog signaling pathway,0.5815193621103911,2.0391638776627397,0.0,0.0,0.0,12/56,18.64%,PTCH1;CSNK1E;PRKACB;SPOPL;CSNK1D;GSK3B;MEGF8;IQCE;PRKACA;CSNK1A1;CUL3;MGRN1
prerank,Chronic myeloid leukemia,0.49765727923355946,2.032098868724729,0.0,0.000750170639673402,0.01,34/76,27.03%,CDK6;SMAD3;AKT3;SHC3;TP53;BCR;HDAC2;MAPK1;CBL;TGFBR2;MAPK3;RB1;AKT1;HDAC1;BAX;KRAS;CDKN2A;PIK3CB;CTBP1;MYC;PIK3CA;NRAS;GRB2;BAD;CRK;SHC1;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;GADD45A;IKBKG;CRKL
prerank,Non-small cell lung cancer,0.5146612025938226,2.0270439540714524,0.0,0.0007175545249049933,0.01,30/72,25.67%,CDK6;EML4;RXRA;AKT3;KIF5B;TP53;MAPK1;MET;PLCG1;MAPK3;STK4;RB1;PRKCA;AKT1;BAX;EGFR;KRAS;CDKN2A;PIK3CB;PRKCG;PIK3CA;NRAS;GRB2;BAD;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;GADD45A
prerank,Endocrine and other factor-regulated calcium reabsorption,0.6081142765074474,2.019865880037979,0.0,0.0006876564197006186,0.01,15/53,18.69%,CLTB;RAB11A;GNAS;PRKACB;ATP2B1;ATP2B4;PRKCA;AP2S1;DNM2;ADCY6;PRKCG;CLTC;AP2M1;PRKACA;DNM1
prerank,Relaxin signaling pathway,0.4621371533152237,2.016096344212716,0.0,0.0006601501629125939,0.01,38/129,23.53%,ATF4;AKT3;SHC3;VEGFA;GNB1;MAPK1;TGFBR2;GNAS;GNG5;PRKACB;MAPK3;CREB3L2;COL4A5;PRKCA;AKT1;GNB5;GNAI2;EGFR;PRKCZ;KRAS;ADCY6;PIK3CB;PIK3CA;PRKACA;NRAS;MAP2K4;GNG12;CREB3;GRB2;ADCY7;VEGFC;MAPK8;SHC1;SMAD2;GNB2;SOS1;AKT2;PIK3R3
prerank,Hepatocellular carcinoma,0.4374693823189813,2.0146801551278695,0.0,0.0006347597720313402,0.01,47/168,23.53%,CDK6;MGST1;SMAD3;AKT3;SHC3;TP53;ACTG1;MTOR;MAPK1;MET;TGFBR2;PLCG1;MAPK3;DVL3;RPS6KB1;GSK3B;RB1;ARID1A;PRKCA;AKT1;KEAP1;BAX;EGFR;KRAS;CDKN2A;GSTM3;PIK3CB;PRKCG;CTNNB1;MYC;PIK3CA;ACTB;NRAS;WNT9A;CSNK1A1;GRB2;IGF1R;DVL1;BAD;SHC1;SMAD2;CDKN1A;NQO1;SOS1;AKT2;ACTL6A;PIK3R3
prerank,Cholinergic synapse,0.5368329206994782,1.9986138700944742,0.0,0.0018337504525349829,0.02,26/113,23.53%,ATF4;AKT3;GNB1;MAPK1;GNG5;PRKACB;MAPK3;ITPR3;CREB3L2;PRKCA;AKT1;GNB5;GNAI2;KRAS;ADCY6;PIK3CB;PRKCG;PIK3CA;PRKACA;NRAS;GNG12;CREB3;ADCY7;GNB2;AKT2;PIK3R3
prerank,Platelet activation,0.480453191391393,1.99589237655693,0.0,0.0017682593649444478,0.02,32/124,26.70%,PRKCI;AKT3;PPP1CA;ACTG1;ROCK1;MAPK1;GNAS;MYL12B;PRKACB;PPP1R12A;MAPK3;ITPR3;AKT1;GNAI2;RAP1B;PRKCZ;ADCY6;LYN;PIK3CB;RAP1A;PIK3CA;PRKACA;ACTB;GNA13;ARHGAP35;ADCY7;MYL12A;AKT2;PIK3R3;ROCK2;MAPK11;ARHGEF12
prerank,GnRH secretion,0.5438269829874207,1.9833107471089968,0.0,0.0028454748401404908,0.04,15/64,23.53%,AKT3;MAPK1;SPP1;MAPK3;ITPR3;PRKCA;AKT1;KRAS;PIK3CB;PRKCG;PIK3CA;NRAS;KCNN4;AKT2;PIK3R3
prerank,AGE-RAGE signaling pathway in diabetic complications,0.4617372791987832,1.9823908960350367,0.0,0.0027506256788024743,0.04,30/100,26.20%,SMAD3;AKT3;VEGFA;MAPK1;TGFBR2;PLCG1;DIAPH1;MAPK3;CDC42;STAT1;COL4A5;PRKCA;AKT1;F3;RAC1;BAX;PRKCZ;KRAS;PIK3CB;PIK3CA;NRAS;VEGFC;MAPK8;SMAD2;AKT2;PIK3R3;FN1;CCND1;PIM1;MAPK11
prerank,Neurotrophin signaling pathway,0.45411922677938477,1.9654160055946193,0.0,0.002661895818195943,0.04,41/119,27.11%,ATF4;AKT3;SHC3;CALML5;TP53;MAPK1;PLCG1;MAPK3;MAP3K1;SORT1;CDC42;PRDM4;GSK3B;AKT1;RPS6KA3;RAP1B;RAC1;BAX;KRAS;CALM2;PIK3CB;RAP1A;PIK3CA;NRAS;CALM1;CALM3;RIPK2;GRB2;YWHAE;MAPK8;BAD;CRK;SHC1;MAGED1;SOS1;AKT2;PIK3R3;MAPK11;RPS6KA1;CRKL;PDPK1
prerank,Human papillomavirus infection,0.38452588764651174,1.9580651693132407,0.0,0.003094453888652784,0.05,82/331,25.42%,PPP2R5E;UBR4;ITGA3;CDK6;LAMA5;PRKCI;AKT3;LAMB1;MFNG;BCAP31;VEGFA;TP53;CDK2;PPP2R1A;NOTCH2;MTOR;HDAC2;ATP6V0C;MAPK1;GNAS;SPP1;TYK2;PRKACB;MAPK3;DVL3;RPS6KB1;CDC42;CREB3L2;THBS1;EIF2AK2;STAT1;DLG1;COL4A5;GSK3B;RB1;ATP6V1F;AKT1;CHD4;HDAC1;IRF3;BAX;EGFR;PRKCZ;KRAS;PIK3CB;TNFRSF1A;CTNNB1;PKM;ATP6V0A1;COL6A1;ATP6AP1;PIK3CA;PRKACA;NRAS;LAMC2;ATR;WNT9A;LAMB2;CSNK1A1;TCIRG1;COL6A2;IFNAR1;CREB3;GRB2;PXN;EP300;DVL1;BAD;SCRIB;CDKN1A;SOS1;AKT2;RHEB;PIK3R3;RFNG;LAMA4;FN1;TUBG1;ITGB4;CCND1;PPP2R5C;RBPJ
prerank,Aminoacyl-tRNA biosynthesis,-0.6336902194419046,-1.954074372483739,0.0,0.007931421246595096,0.06,12/66,25.77%,MARS2;FARSB;PARS2;FARS2;RARS2;LARS2;GATB;FARSA;EARS2;TARS2;HARS2;CARS2
prerank,Pathways in cancer,0.3620660367853153,1.9461257499233846,0.0,0.0030006825586936085,0.05,115/531,26.70%,TPR;ITGA3;CDK6;MGST1;LAMA5;EML4;SMAD3;PTCH1;RXRA;AKT3;MSH3;LAMB1;SLC2A1;VEGFA;CALML5;GNA12;TP53;CDK2;GNB1;BCR;NOTCH2;SKP1;MTOR;ROCK1;HDAC2;MAPK1;CBL;MET;TGFBR2;SP1;PLCG1;GNAS;GNG5;PRKACB;MAPK3;DVL3;BIRC2;RPS6KB1;STK4;DAPK1;CDC42;STAT1;COL4A5;PMAIP1;GSK3B;RB1;PRKCA;AKT1;GNB5;KEAP1;BIRC3;GNAI2;RAC1;HDAC1;TPM3;ELOB;BAX;EGFR;CCDC6;KRAS;CDKN2A;TFG;GSTM3;CALM2;ADCY6;IL6ST;PIK3CB;PRKCG;CTNNB1;HSP90B1;NCOA4;CTBP1;MYC;PIK3CA;PRKACA;NRAS;CALM1;LAMC2;CALM3;WNT9A;GNG12;LAMB2;GNA13;CUL2;IFNAR1;GRB2;RALA;ADCY7;TRAF2;VEGFC;MAPK8;EP300;IGF1R;DVL1;BAD;CRK;SMAD2;CDKN1A;GNB2;NQO1;SOS1;AKT2;PIK3R3;LAMA4;FN1;CCND1;CTNNA1;PIM1;ROCK2;NFKB2;GADD45A;HSP90AA1;PTK2;IKBKG;ARHGEF12
prerank,Ras signaling pathway,0.4093380702741144,1.921264795755135,0.0,0.0038832362524270224,0.07,50/232,23.53%,ABL2;PAK2;AKT3;SHC3;VEGFA;CALML5;GNB1;MAPK1;MET;PLCG1;GNG5;PRKACB;MAPK3;STK4;CDC42;BRAP;PAK1;CSF1;PRKCA;AKT1;GNB5;RAP1B;RAC1;EGFR;KRAS;CALM2;RASA1;PIK3CB;PRKCG;RAP1A;PIK3CA;PRKACA;NRAS;CALM1;CALM3;GNG12;AFDN;GRB2;RALA;RRAS2;VEGFC;MAPK8;IGF1R;SHOC2;BAD;SHC1;GNB2;SOS1;AKT2;PIK3R3
prerank,Leukocyte transendothelial migration,0.45825889480411236,1.9171998648324895,0.0,0.004243822475866675,0.08,31/114,26.59%,VCL;ACTG1;ROCK1;ACTN4;CLDN1;PLCG1;MYL12B;EZR;CDC42;PRKCA;GNAI2;RAP1B;RAC1;PIK3CB;PRKCG;CTNNB1;RAP1A;PIK3CA;ACTB;AFDN;ARHGAP35;PXN;CTNND1;MYL12A;MYL5;PIK3R3;MSN;CTNNA1;ROCK2;MAPK11;PTK2
prerank,Chemokine signaling pathway,0.44140688543805934,1.902731379529856,0.0,0.004584376131337457,0.09,42/192,27.03%,AKT3;SHC3;GNB1;ROCK1;MAPK1;PLCG1;GNG5;PRKACB;MAPK3;CDC42;PAK1;STAT1;GSK3B;AKT1;GNB5;GNAI2;RAP1B;RAC1;PRKCZ;KRAS;ADCY6;LYN;PIK3CB;RAP1A;PIK3CA;PRKACA;NRAS;GNG12;GRB2;PXN;ADCY7;BAD;CRK;SHC1;GNB2;SOS1;AKT2;PIK3R3;ROCK2;PTK2;IKBKG;CRKL
prerank,Oxytocin signaling pathway,0.4753000292515363,1.9013340170325965,0.0,0.004460474073733742,0.09,26/154,17.09%,CALML5;PPP1R12C;PPP1CA;ACTG1;ROCK1;MAPK1;GNAS;PRKAA1;PRKACB;PPP1R12A;MAPK3;ITPR3;PRKCA;CACNG6;GNAI2;PRKAB1;EGFR;KRAS;CALM2;ADCY6;PRKCG;PRKACA;ACTB;NRAS;CALM1;CALM3
prerank,PI3K-Akt signaling pathway,0.38878966826415773,1.895901228497461,0.0,0.004343093177056539,0.09,73/354,25.23%,PPP2R5E;OSMR;ATF4;ITGA3;CDK6;LAMA5;MCL1;RXRA;AKT3;LAMB1;VEGFA;TP53;CDK2;GNB1;PPP2R1A;MTOR;YWHAZ;MAPK1;MET;PRKAA1;SPP1;GNG5;MAPK3;RPS6KB1;CREB3L2;THBS1;YWHAG;COL4A5;GSK3B;CSF1;PKN2;PRKCA;AKT1;GNB5;RPTOR;RAC1;EGFR;EIF4B;KRAS;EIF4E2;ERBB3;PIK3CB;HSP90B1;MYC;COL6A1;RPS6;PIK3CA;NRAS;LAMC2;GYS1;YWHAB;GNG12;LAMB2;COL6A2;IFNAR1;CREB3;GRB2;MLST8;VEGFC;YWHAE;IGF1R;BAD;CDKN1A;GNB2;SOS1;AKT2;RHEB;PIK3R3;LAMA4;FN1;ITGB4;CCND1;PPP2R5C
prerank,Amphetamine addiction,0.5134795152554666,1.8884934133309763,0.0,0.005078078176250722,0.11,16/69,18.55%,ATF4;CALML5;PPP1CA;HDAC2;SIRT1;GNAS;PRKACB;CREB3L2;PRKCA;HDAC1;CALM2;PRKCG;PRKACA;CALM1;CALM3;CREB3
prerank,Long-term potentiation,0.5175444391623252,1.88479512565989,0.0,0.005776313925485197,0.12,18/67,17.09%,ATF4;CALML5;PPP1CA;MAPK1;PRKACB;MAPK3;ITPR3;PRKCA;RPS6KA3;RAP1B;KRAS;CALM2;PRKCG;RAP1A;PRKACA;NRAS;CALM1;CALM3
prerank,Glutamatergic synapse,0.5101409596798763,1.8827748823344803,0.0,0.005635428219985558,0.12,17/114,19.17%,GNB1;SLC38A1;MAPK1;GNAS;SLC38A2;GNG5;PRKACB;MAPK3;ITPR3;PRKCA;GNB5;GNAI2;ADCY6;PRKCG;PRKACA;GNG12;ADCY7
prerank,Dopaminergic synapse,0.439826167737612,1.8822366417308019,0.0,0.005501251357604949,0.12,26/132,19.87%,PPP2R5E;ATF4;AKT3;KIF5B;CALML5;GNB1;PPP1CA;PPP2R1A;GNAS;GNG5;PRKACB;ITPR3;CREB3L2;GSK3B;PRKCA;AKT1;GNB5;GNAI2;CALM2;PRKCG;PRKACA;CALM1;CALM3;GNG12;CREB3;MAPK8
prerank,cAMP signaling pathway,0.4395164696187926,1.8793020727670278,0.0,0.005373315279521113,0.12,37/216,23.53%,PTCH1;AKT3;CALML5;PPP1CA;ROCK1;MAPK1;GNAS;PRKACB;PPP1R12A;SLC9A1;MAPK3;PAK1;CREB3L2;ATP2B1;ATP2B4;AKT1;GNAI2;RAP1B;RAC1;CALM2;ADCY6;PIK3CB;RAP1A;PIK3CA;PRKACA;CALM1;CALM3;CREB3;AFDN;ADCY7;RRAS2;MAPK8;EP300;BAD;ATP1A1;AKT2;PIK3R3
prerank,GABAergic synapse,0.5067491717866022,1.873619903154276,0.0,0.005626279797550515,0.13,15/89,19.17%,GNB1;SLC38A1;SLC38A2;GNG5;PRKACB;ABAT;PRKCA;GNB5;GNAI2;GABARAP;ADCY6;PRKCG;PRKACA;GNG12;ADCY7
prerank,Melanoma,0.4919945274363077,1.8713027534287814,0.0,0.005501251357604949,0.13,22/72,25.67%,CDK6;AKT3;TP53;MAPK1;MET;MAPK3;RB1;AKT1;BAX;EGFR;KRAS;CDKN2A;PIK3CB;PIK3CA;NRAS;IGF1R;BAD;CDKN1A;AKT2;PIK3R3;CCND1;GADD45A
prerank,Fluid shear stress and atherosclerosis,0.42898011516358736,1.8665690477913706,0.0,0.005740436199239946,0.14,42/139,30.14%,MGST1;AKT3;VEGFA;CALML5;TP53;ACTG1;PRKAA1;AKT1;ASS1;KEAP1;RAC1;PRKCZ;GSTM3;CALM2;PIK3CB;TNFRSF1A;CTNNB1;HSP90B1;PIK3CA;SUMO1;ACTB;CALM1;CALM3;MAP2K4;MAP3K7;GPC1;MAPK8;CAV1;NQO1;AKT2;PIK3R3;SQSTM1;SDC1;SUMO2;MAPK11;HSP90AA1;PTK2;IKBKG;KLF2;RAC2;PIAS4;PIK3R2
prerank,Regulation of lipolysis in adipocytes,0.5949794322925498,1.8653601159866997,0.0,0.005618299258830586,0.14,13/55,23.53%,AKT3;GNAS;PRKACB;MGLL;AKT1;GNAI2;ADCY6;PIK3CB;PIK3CA;PRKACA;ADCY7;AKT2;PIK3R3
prerank,MAPK signaling pathway,0.37468430300310385,1.8648829133151048,0.0,0.005501251357604949,0.14,57/294,20.64%,ATF4;ELK4;PAK2;TAOK1;CDC25B;AKT3;PPP5C;FLNA;TAOK2;VEGFA;GNA12;TP53;FLNB;MAP3K2;MAPK1;MET;TGFBR2;PRKACB;MAPK3;FLNC;STK4;MAP3K1;CDC42;PAK1;MKNK2;CSF1;PRKCA;AKT1;CACNG6;RPS6KA3;RAP1B;RAC1;EGFR;KRAS;ERBB3;RASA1;MKNK1;TAB2;PRKCG;TNFRSF1A;MYC;RAP1A;PRKACA;HSPB1;NRAS;STMN1;MAP2K4;GNG12;GRB2;TRAF2;RRAS2;VEGFC;MAP3K7;MAPK8;LAMTOR3;IGF1R;STK3
prerank,Melanogenesis,0.47206806416483577,1.8606333569043865,0.015384615384615385,0.0053889809217354595,0.14,24/101,20.98%,CALML5;MAPK1;GNAS;PRKACB;MAPK3;DVL3;CREB3L2;GSK3B;PRKCA;GNAI2;KRAS;CALM2;ADCY6;PRKCG;CTNNB1;PRKACA;NRAS;CALM1;CALM3;WNT9A;CREB3;ADCY7;EP300;DVL1
prerank,Endocytosis,0.3560483114137224,1.8559357216729202,0.0,0.005281201303300751,0.14,65/252,24.83%,ARAP1;CLTB;SMAD3;WASL;PRKCI;KIF5B;RAB11A;ARFGEF2;RAB22A;NEDD4;ACAP2;CAPZB;CBL;TGFBR2;VPS25;LDLRAP1;SNF8;ARF1;RAB31;ARF4;ARF5;EHD1;CDC42;SH3GLB1;AGAP3;MVB12A;PDCD6IP;ARF3;EHD2;AP2S1;HGS;WASHC4;ACAP3;EGFR;ARPC1B;PRKCZ;CHMP2A;DNM2;ARPC3;CLTC;VPS26A;AP2M1;VTA1;SH3GLB2;VPS36;AGAP4;NEDD4L;VPS29;VPS35;DNM1;WASHC5;IGF1R;CAV1;AGAP1;CAPZA1;SNX6;STAMBP;SMAD2;ITCH;ACTR3C;ARPC5;SNX4;GBF1;USP8;ACTR2
prerank,"Growth hormone synthesis, secretion and action",0.4549813529579039,1.8514564564735503,0.0,0.0051776483365693635,0.14,36/119,23.53%,ATF4;AKT3;SHC3;MTOR;MAPK1;PLCG1;GNAS;PRKACB;MAPK3;ITPR3;MAP3K1;CREB3L2;STAT1;GSK3B;PRKCA;AKT1;GNAI2;KRAS;ADCY6;PIK3CB;PRKCG;PIK3CA;PRKACA;NRAS;MAP2K4;IGFBP3;CREB3;GRB2;ADCY7;MAPK8;EP300;CRK;SHC1;SOS1;AKT2;PIK3R3
prerank,Aldosterone synthesis and secretion,0.4964087526093467,1.844290619702662,0.0,0.006030217834297732,0.16,20/98,19.17%,ATF4;CALML5;PRKD2;GNAS;PRKACB;ITPR3;CREB3L2;SCARB1;ATP2B1;ATP2B4;PRKCA;CALM2;ADCY6;PRKCG;DAGLB;PRKACA;CALM1;CALM3;CREB3;ADCY7
prerank,Longevity regulating pathway,0.44559518398898496,1.8374703181279244,0.0,0.006227831725590508,0.17,32/102,23.53%,EHMT1;ATF4;AKT3;AKT1S1;TP53;MTOR;HDAC2;SIRT1;PRKAA1;PRKACB;RPS6KB1;CREB3L2;EIF4EBP2;AKT1;RPTOR;PRKAB1;HDAC1;ATG5;BAX;KRAS;EIF4E2;ADCY6;PIK3CB;PIK3CA;PRKACA;NRAS;CREB3;ADCY7;IGF1R;AKT2;RHEB;PIK3R3
prerank,Hippo signaling pathway,0.39845231535117726,1.8368126564522693,0.0,0.0064181265838724405,0.18,38/163,22.97%,SMAD3;PRKCI;CSNK1E;PPP1CA;ACTG1;PPP2R1A;YWHAZ;TGFBR2;DVL3;BIRC2;FRMD6;TEAD1;CSNK1D;PAK1;YWHAG;DLG1;GSK3B;LIMD1;BIRC3;MOB1A;PRKCZ;DLG5;CTNNB1;MYC;ACTB;YWHAB;WNT9A;YAP1;YWHAE;NF2;CCN2;STK3;DVL1;SCRIB;SAV1;SMAD2;TP53BP2;LATS2
prerank,Chemical carcinogenesis,0.3970463913600515,1.8288963568523466,0.0,0.006901569884995299,0.19,41/239,19.17%,ATF4;MGST1;RXRA;AKT3;VEGFA;NOTCH2;MTOR;MAPK1;GNAS;KPNA6;PRKACB;MAPK3;CYP1B1;RPS6KB1;KPNA1;CREB3L2;RB1;PRKCA;AKT1;UGT1A6;KPNA4;RPS6KA3;GNAI2;KPNA3;EGFR;AKR1C2;KRAS;GSTM3;ADCY6;PIK3CB;PRKCG;HSP90B1;SULT1A3;MYC;PIK3CA;PRKACA;NRAS;UGT1A3;CREB3;GRB2;ADCY7
prerank,Thyroid cancer,0.5218174103843521,1.8240907938270017,0.0,0.007073037459777791,0.2,14/37,16.64%,TPR;RXRA;TP53;MAPK1;MAPK3;TPM3;BAX;CCDC6;KRAS;TFG;CTNNB1;NCOA4;MYC;NRAS
prerank,Regulation of actin cytoskeleton,0.3807058494317142,1.8208129503498218,0.0,0.007238488628427564,0.2,60/218,27.03%,ITGA3;VCL;WASL;PAK2;PPP1R12C;GNA12;PPP1CA;ACTG1;ROCK1;ACTN4;MYH9;MAPK1;MYL12B;DIAPH1;MYH14;CFL1;PPP1R12A;EZR;SLC9A1;CYFIP1;MAPK3;FGD1;LIMK1;CDC42;PAK1;WASF2;RAC1;EGFR;NCKAP1;ARPC1B;KRAS;ARPC3;PIK3CB;PIK3CA;ACTB;NRAS;GNG12;ENAH;GNA13;ARHGAP35;PXN;RRAS2;MYL12A;DIAPH3;CRK;MYL5;SOS1;ACTR3C;PIK3R3;ARPC5;FN1;ITGB4;LIMK2;MSN;ACTR2;ROCK2;RDX;PTK2;ARHGEF12;CRKL
prerank,Aldosterone-regulated sodium reabsorption,0.5927493563309858,1.8193626215273855,0.0,0.007113687100351227,0.2,15/37,30.14%,MAPK1;MAPK3;PRKCA;KRAS;SLC9A3R2;PIK3CB;PRKCG;PIK3CA;NEDD4L;SCNN1A;ATP1A1;SFN;PIK3R3;PDPK1;PIK3R2
prerank,Kaposi sarcoma-associated herpesvirus infection,0.3894893047348587,1.811030323351951,0.0,0.007832290068454503,0.23,46/193,20.26%,CDK6;AKT3;VEGFA;CALML5;TP53;GNB1;MTOR;MAPK1;PLCG1;TYK2;GNG5;MAPK3;ITPR3;PIK3C3;EIF2AK2;STAT1;GSK3B;RB1;AKT1;GNB5;RAC1;GABARAP;BECN1;IRF3;RPS27A;BAX;KRAS;CALM2;IL6ST;LYN;PIK3CB;TNFRSF1A;CTNNB1;MYC;UBB;PIK3CA;NRAS;CALM1;CALM3;MAP2K4;GNG12;IFNAR1;C3;TRAF2;MAPK8;EP300
prerank,Long-term depression,0.5161280928120111,1.8046169907981842,0.0,0.007976814468527176,0.24,14/60,20.46%,GNA12;PPP2R1A;MAPK1;GNAS;MAPK3;ITPR3;PRKCA;GNAI2;KRAS;LYN;PRKCG;NRAS;GNA13;IGF1R
prerank,Retrograde endocannabinoid signaling,0.4140926857784808,1.8046019328889253,0.0,0.00784604701822345,0.24,31/148,26.20%,NDUFB7;GNB1;MAPK1;NDUFA4;NDUFC2;GNG5;PRKACB;MAPK3;ITPR3;MGLL;PRKCA;GNB5;GNAI2;NDUFB2;NDUFS5;ADCY6;NDUFS2;PRKCG;DAGLB;PRKACA;GNG12;ADCY7;MAPK8;NDUFA5;NDUFC1;GNB2;NDUFA1;NDUFB6;NDUFA13;NDUFA10;MAPK11
prerank,Rap1 signaling pathway,0.4079093909792849,1.8027691192130104,0.0,0.007719497872768234,0.24,42/210,20.74%,PRKCI;AKT3;VEGFA;CALML5;ACTG1;PRKD2;MAPK1;MET;PLCG1;GNAS;SIPA1L3;MAPK3;CDC42;THBS1;CSF1;PRKCA;AKT1;GNAI2;RAP1B;RAC1;EGFR;PRKCZ;KRAS;RAP1GAP;CALM2;ADCY6;PIK3CB;PRKCG;CTNNB1;RAP1A;PIK3CA;ACTB;NRAS;CALM1;CALM3;ENAH;AFDN;RALA;ADCY7;VEGFC;IGF1R;CTNND1
prerank,Shigellosis,0.36514444085138636,1.8012889739028353,0.0,0.007596966160502071,0.24,86/246,31.94%,VCL;WASL;AKT3;AKT1S1;CTTN;UBE2D3;CAPN1;TP53;ACTG1;SKP1;MTOR;ROCK1;ACTN4;CAPNS1;MAPK1;PLCG1;MYL12B;DIAPH1;MAPK3;ARF1;ITPR3;RPS6KB1;CDC42;PIK3C3;GSK3B;WASF2;AKT1;RPTOR;RAC1;GABARAP;ATG5;CAST;BECN1;IRF3;HK1;RPS27A;BAX;EGFR;ARPC1B;ARPC3;TAB2;PIK3CB;TNFRSF1A;UBB;PIK3CA;ACTB;RIPK2;C3;PXN;TRAF2;MAP3K7;CD44;MAPK8;MYL12A;CASP4;CRK;MYL5;AKT2;ACTR3C;CAPN2;PIK3R3;SQSTM1;ARPC5;WIPI2;ACTR2;ROCK2;MAPK11;TAB3;PTK2;IKBKG;CRKL;CBX3;BCL10;UBE2V1;PIK3R4;ACTN1;ATG12;PIK3R2;CYCS;ATG16L1;UBC;UBA52;RBCK1;RRAGC;CUL1;ARPC4
prerank,Amoebiasis,0.45904993076238965,1.8005647961196354,0.0,0.007478263564244227,0.24,25/102,30.14%,VCL;LAMA5;LAMB1;ACTN4;GNAS;PRKACB;COL4A5;PRKCA;PIK3CB;PRKCG;PRDX1;PIK3CA;PRKACA;HSPB1;LAMC2;LAMB2;PIK3R3;LAMA4;FN1;PTK2;RAB7A;GNA11;ACTN1;LAMB3;PIK3R2
prerank,Base excision repair,-0.49118866839675696,-1.792731344565295,0.0,0.019387918602788014,0.18,12/33,17.44%,SMUG1;PCNA;NEIL3;FEN1;POLE;UNG;POLD1;POLE2;POLD3;PARP1;POLB;APEX2
prerank,GnRH signaling pathway,0.4432660880545566,1.7912932220171296,0.0,0.007617117264376083,0.24,23/93,19.87%,ATF4;CALML5;MAP3K2;MAPK1;GNAS;PRKACB;MAPK3;ITPR3;MAP3K1;CDC42;PRKCA;EGFR;KRAS;CALM2;ADCY6;PRKACA;NRAS;CALM1;CALM3;MAP2K4;GRB2;ADCY7;MAPK8
prerank,Renal cell carcinoma,0.42031005531576493,1.786633829570456,0.0,0.00800182015651629,0.26,27/69,23.53%,PAK2;AKT3;SLC2A1;VEGFA;MAPK1;MET;MAPK3;CDC42;PAK1;AKT1;RAP1B;RAC1;ELOB;KRAS;PIK3CB;RAP1A;PIK3CA;NRAS;CUL2;GRB2;EP300;BAD;CRK;CDKN1A;SOS1;AKT2;PIK3R3
prerank,Tight junction,0.3817390472189654,1.7524859073091184,0.0,0.009606662818504164,0.31,42/169,25.16%,PRKCI;CTTN;NEDD4;ACTG1;PPP2R1A;ROCK1;ACTN4;MYH9;CLDN1;MYL12B;PRKAA1;MYH14;PRKACB;EZR;MAP3K1;AMOTL2;CDC42;DLG1;PRKAB1;RAC1;ARPC1B;PRKCZ;ARHGAP17;ARPC3;YBX3;RAP1A;PRKACA;ACTB;TJP2;NEDD4L;AFDN;MAPK8;NF2;MYL12A;SCRIB;ACTR3C;ARPC5;TUBA1C;MSN;CCND1;ACTR2;ROCK2
prerank,Cardiac muscle contraction,0.4858101925562055,1.7439718339312222,0.0,0.010921601959951002,0.33,18/87,23.13%,COX6A1;COX6B1;COX4I1;SLC9A1;UQCRB;TPM1;CACNG6;TPM3;COX5A;UQCRC2;COX7A2;TPM4;TPM2;UQCR10;UQCR11;ATP1A1;COX7C;UQCRQ
prerank,Morphine addiction,0.5124179030228578,1.7372347467143154,0.018518518518518517,0.011480872398479893,0.34,13/91,22.63%,GNB1;GNAS;GNG5;PRKACB;PRKCA;GNB5;GNAI2;ADCY6;PRKCG;PRKACA;GNG12;ADCY7;GNB2
prerank,Gastric cancer,0.4130394351276546,1.7361813234070569,0.0,0.01155262785097039,0.35,37/149,25.67%,SMAD3;RXRA;AKT3;SHC3;TP53;CDK2;MTOR;MAPK1;MET;TGFBR2;MAPK3;DVL3;RPS6KB1;GSK3B;RB1;AKT1;BAX;EGFR;KRAS;PIK3CB;CTNNB1;MYC;PIK3CA;NRAS;WNT9A;CSNK1A1;GRB2;DVL1;SHC1;SMAD2;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;CTNNA1;GADD45A
prerank,Lysine degradation,0.41814254610564805,1.7275623538415703,0.0,0.01231970374449559,0.37,20/63,24.20%,EHMT1;DOT1L;KMT2B;KMT2D;ASH1L;DLD;SETD2;PLOD1;ALDH3A2;KMT5A;ACAT2;NSD2;ALDH1B1;HADHA;PHYKPL;SETD7;KMT5B;PLOD3;DLST;GCDH
prerank,Small cell lung cancer,0.4036190627708216,1.7174526063060427,0.0,0.013065471974311751,0.38,29/92,26.68%,ITGA3;CDK6;LAMA5;RXRA;AKT3;LAMB1;TP53;CDK2;BIRC2;COL4A5;RB1;AKT1;BIRC3;BAX;PIK3CB;MYC;PIK3CA;LAMC2;LAMB2;TRAF2;CDKN1A;AKT2;PIK3R3;LAMA4;FN1;CCND1;GADD45A;PTK2;IKBKG
prerank,Human cytomegalovirus infection,0.3685738331437403,1.7149175499650202,0.0,0.013112571729085767,0.38,65/225,27.03%,ATF4;CDK6;AKT3;VEGFA;CALML5;GNA12;TP53;GNB1;MTOR;ROCK1;MAPK1;SP1;GNAS;GNG5;PRKACB;MAPK3;ITPR3;RPS6KB1;B2M;CREB3L2;GSK3B;RB1;PRKCA;AKT1;GNB5;GNAI2;RAC1;IRF3;BAX;EGFR;KRAS;CDKN2A;CALM2;ADCY6;PIK3CB;PRKCG;TNFRSF1A;CTNNB1;MYC;PIK3CA;PRKACA;NRAS;CALM1;CALM3;GNG12;GNA13;CREB3;GRB2;PXN;ADCY7;TRAF2;CRK;CDKN1A;GNB2;SOS1;AKT2;RHEB;PIK3R3;CCND1;ROCK2;MAPK11;PTK2;IKBKG;ARHGEF12;CRKL
prerank,Inflammatory mediator regulation of TRP channels,0.45587383759474276,1.7135427123658882,0.0,0.013158398517514542,0.39,19/98,23.75%,CALML5;PPP1CA;PLCG1;GNAS;PRKACB;ITPR3;PRKCA;CALM2;ADCY6;PIK3CB;PRKCG;PIK3CA;PRKACA;CALM1;CALM3;ADCY7;MAPK8;PIK3R3;PRKCH
prerank,Ubiquitin mediated proteolysis,0.3643812288294991,1.7124271936110795,0.0,0.013203003258251876,0.39,61/140,33.46%,HERC1;UBE2D3;NEDD4;FZR1;SKP1;MID1;UBE2F;CBL;BIRC2;MAP3K1;KEAP1;BIRC3;ELOB;RPS27A;UBE4B;ANAPC13;UBB;PIAS1;UBE2J1;UBE2L3;TRIP12;STUB1;UBE2A;CUL5;CUL2;NEDD4L;CUL3;HUWE1;MGRN1;UBE4A;UBE3C;UBE2G1;KLHL9;UBE2H;UBE2J2;UBE2R2;UBA6;CDC16;ITCH;UBE2K;ANAPC1;UBE2G2;UBE2O;ANAPC2;HERC2;UBE2E3;UBE2Z;UBE2E1;UBE2C;HERC4;CDC34;PIAS4;CUL4B;WWP2;UBC;UBA52;CUL1;BIRC6;FBXW11;UBE3B;ANAPC5
prerank,Hepatitis C,0.3837864506696251,1.7043441350838398,0.018518518518518517,0.014332207484286577,0.43,41/157,23.53%,CDK6;RXRA;AKT3;TP53;CDK2;PPP2R1A;YWHAZ;CLDN1;MAPK1;TYK2;MAPK3;EIF2AK1;SCARB1;YWHAG;EIF2AK2;STAT1;GSK3B;RB1;AKT1;IRF3;BAX;EGFR;KRAS;PIK3CB;TNFRSF1A;CTNNB1;MYC;PIK3CA;PIAS1;NRAS;YWHAB;EIF3E;IFNAR1;GRB2;TRAF2;YWHAE;BAD;CDKN1A;SOS1;AKT2;PIK3R3
prerank,Synaptic vesicle cycle,0.4722683023466536,1.7023307472152303,0.018867924528301886,0.014146074919555583,0.43,12/78,22.45%,CLTB;ATP6V0C;ATP6V1F;AP2S1;DNM2;ATP6V0A1;CLTC;AP2M1;TCIRG1;DNM1;VAMP2;NAPA
prerank,Diabetic cardiomyopathy,0.34985285457550513,1.7007593488602764,0.0,0.013964714984689486,0.43,53/203,26.20%,SMAD3;ATP5PD;AKT3;NDUFB7;COX6A1;SLC2A1;COX6B1;PPP1CA;MTOR;TGFBR2;GFPT1;NDUFA4;NDUFC2;SP1;COX4I1;UQCRB;SDHA;GSK3B;CTSD;PRKCA;AKT1;RAC1;COX5A;NDUFB2;PDK2;UQCRC2;PRKCZ;NDUFS5;ATP5PB;NDUFS2;PIK3CB;PRKCG;COX7A2;PIK3CA;GYS1;PDHB;UQCR10;VDAC2;MAPK8;UQCR11;NDUFA5;NDUFC1;SMAD2;COX7C;AKT2;UQCRQ;PIK3R3;NDUFA1;NDUFB6;NDUFA13;NDUFA10;ATP5F1B;MAPK11
prerank,Thermogenesis,0.3469181939468315,1.6967938082400524,0.0,0.014205762999384931,0.43,67/232,27.18%,ATP5PD;AKT1S1;NDUFB7;KDM1A;COX6A1;COX6B1;ATP5MF;ACTG1;MTOR;NDUFA4;NDUFC2;COX4I1;GNAS;PRKAA1;PRKACB;UQCRB;RPS6KB1;CREB3L2;MGLL;SDHA;ARID1A;COA1;RPS6KA3;RPTOR;PRKAB1;ACSL1;COX5A;NDUFB2;COX16;UQCRC2;KRAS;NDUFS5;ATP5PB;ADCY6;NDUFS2;ACSL4;COX7A2;RPS6;PRKACA;ACTB;NRAS;CREB3;GRB2;ADCY7;UQCR10;MLST8;KDM3A;UQCR11;NDUFA5;NDUFC1;COX7C;COA4;SOS1;ACTL6A;UQCRQ;RHEB;NDUFA1;NDUFB6;COA5;NDUFA13;NDUFA10;ATP5F1B;MAPK11;COX14;ATP5MG;RPS6KA1;SMARCC2
prerank,Glucagon signaling pathway,0.43213920600240757,1.6954324809401093,0.0,0.01402819096189262,0.43,26/107,18.66%,ATF4;AKT3;PYGL;SLC2A1;CALML5;PRMT1;SIRT1;PFKP;GNAS;PRKAA1;PRKACB;ITPR3;PHKB;CREB3L2;AKT1;PRKAB1;CALM2;PPP4R3B;PKM;PRKACA;CALM1;GYS1;CALM3;PPP4C;CREB3;PDHB
prerank,Insulin secretion,0.48668077556850065,1.6911488286788925,0.0,0.0144662535699982,0.44,15/86,22.01%,ATF4;SLC2A1;GNAS;PRKACB;ITPR3;CREB3L2;PRKCA;ADCY6;PRKCG;PRKACA;CREB3;ADCY7;VAMP2;KCNN4;ATP1A1
prerank,Thyroid hormone synthesis,0.4688697366066999,1.671201491473897,0.01694915254237288,0.017711345834240323,0.5,16/75,19.17%,ATF4;GPX2;GNAS;PRKACB;ITPR3;CREB3L2;PRKCA;PDIA4;ADCY6;GPX8;PRKCG;HSP90B1;GPX3;PRKACA;CREB3;ADCY7
prerank,Serotonergic synapse,0.4841421604716907,1.6641637034694032,0.0,0.01789563694642574,0.5,16/113,17.34%,GNB1;MAPK1;GNAS;GNG5;PRKACB;MAPK3;APP;ITPR3;PRKCA;GNB5;GNAI2;KRAS;PRKCG;PRKACA;NRAS;GNG12
prerank,Breast cancer,0.3913951207774787,1.6634961323722113,0.0,0.01807554017498769,0.5,35/147,25.67%,CDK6;AKT3;SHC3;TP53;NOTCH2;MTOR;MAPK1;SP1;MAPK3;DVL3;RPS6KB1;GSK3B;RB1;AKT1;BAX;EGFR;KRAS;PIK3CB;CTNNB1;MYC;PIK3CA;NRAS;WNT9A;CSNK1A1;GRB2;IGF1R;DVL1;SHC1;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;NFKB2;GADD45A
prerank,Pathogenic Escherichia coli infection,0.3409770563117361,1.6579160247140705,0.0,0.019416181262135113,0.53,49/197,26.70%,ABCF2;WASL;PAK2;CTTN;GNA12;ACTG1;RAB1A;ROCK1;MYH9;CLDN1;MAPK1;RPS3;MYH14;EZR;CYFIP1;MAPK3;ARF1;CDC42;PAK1;WASF2;TMED10;RAC1;MYO1C;BAX;NCKAP1;ARPC1B;SEC24C;ARPC3;TMBIM6;TAB2;TNFRSF1A;NCK1;ACTB;GNA13;MYO10;TRAF2;MAP3K7;MAPK8;CASP4;ACTR3C;ARPC5;TUBA1C;ACTR2;ROCK2;BAIAP2L1;MAPK11;TAB3;IKBKG;ARHGEF12
prerank,ECM-receptor interaction,0.4380459332012682,1.6571197055880449,0.0,0.019382315829701156,0.53,18/88,24.55%,ITGA3;LAMA5;AGRN;LAMB1;SPP1;THBS1;COL4A5;CD47;COL6A1;LAMC2;LAMB2;COL6A2;CD44;HMMR;LAMA4;FN1;ITGB4;SDC1
prerank,mRNA surveillance pathway,0.3588910944770844,1.6526444203650457,0.0,0.019918323880983434,0.54,24/98,19.11%,PPP2R5E;SMG1;PABPC1L;CASC3;PABPN1;FUS;CSTF2T;PPP1CA;PPP2R1A;RNPS1;BCL2L2-PABPN1;UPF2;DAZAP1;CPSF6;PCF11;GSPT1;PNN;CSTF3;PABPC1;EIF4A3;PABPC4;TARDBP;MAGOH;CSTF1
prerank,Viral carcinogenesis,0.3434709996289304,1.6475891530260696,0.0,0.020067064611263504,0.54,51/203,25.42%,UBR4;ATF4;CDK6;TP53;CDK2;YWHAZ;HDAC2;ACTN4;MAPK1;PRKACB;MAPK3;LTBR;CDC42;CREB3L2;YWHAG;EIF2AK2;DLG1;PMAIP1;RB1;SND1;CHD4;RAC1;HDAC1;IRF3;BAX;KRAS;CDKN2A;IL6ST;LYN;PIK3CB;PKM;PIK3CA;PRKACA;NRAS;YWHAB;CREB3;C3;GRB2;PXN;TRAF2;YWHAE;EP300;DDX3X;BAD;SCRIB;CDKN1A;PIK3R3;MAD1L1;CCND1;NFKB2;RBPJ
prerank,Sphingolipid signaling pathway,0.36914520022720854,1.6458886051226083,0.017857142857142856,0.019841591975181892,0.54,37/119,30.14%,PPP2R5E;AKT3;SPTLC2;GNA12;TP53;PPP2R1A;ROCK1;MAPK1;MAPK3;CTSD;PRKCA;AKT1;GNAI2;RAC1;BAX;PRKCZ;KRAS;PIK3CB;PRKCG;TNFRSF1A;PIK3CA;NRAS;GNA13;TRAF2;MAPK8;DEGS1;AKT2;PIK3R3;ROCK2;PPP2R5C;MAPK11;PDPK1;SPTLC1;SGMS1;RAC2;CERS2;PIK3R2
prerank,Cholesterol metabolism,0.4427978728741606,1.645207267451859,0.0,0.01962112984212432,0.54,11/50,20.70%,VAPB;LDLRAP1;MYLIP;SORT1;SCARB1;LIPA;PCSK9;VAPA;VDAC2;NPC2;TSPO
prerank,Alcoholism,0.39786552226763805,1.6441099940235606,0.0,0.019586872965538498,0.54,27/186,22.98%,ATF4;SHC3;CALML5;GNB1;PPP1CA;HDAC2;MAPK1;GNAS;GNG5;PRKACB;MAPK3;CREB3L2;GNB5;GNAI2;HDAC1;KRAS;CALM2;PRKACA;NRAS;CALM1;CALM3;GNG12;CREB3;GRB2;SHC1;GNB2;SOS1
prerank,Bladder cancer,0.458428287962875,1.64182175792459,0.02,0.01955336080366107,0.55,12/41,16.64%,VEGFA;TP53;MAPK1;MAPK3;DAPK1;THBS1;RB1;EGFR;KRAS;CDKN2A;MYC;NRAS
prerank,HIF-1 signaling pathway,0.37782827791396956,1.6298651554395085,0.0,0.02165008598799367,0.56,31/109,23.53%,AKT3;SLC2A1;VEGFA;MTOR;MAPK1;PFKP;PLCG1;MAPK3;RPS6KB1;LTBR;MKNK2;PRKCA;AKT1;ELOB;HK1;EGFR;EIF4E2;ALDOA;MKNK1;PIK3CB;PRKCG;RPS6;PIK3CA;ENO1;CUL2;PDHB;EP300;IGF1R;CDKN1A;AKT2;PIK3R3
prerank,"Parathyroid hormone synthesis, secretion and action",0.40977717882641446,1.6268378458463497,0.0,0.021946481479806976,0.57,20/106,19.17%,ATF4;RXRA;GNA12;MAPK1;SP1;GNAS;PRKACB;MAPK3;ITPR3;CREB3L2;PRKCA;GNAI2;EGFR;ADCY6;PRKCG;PRKACA;NACA;GNA13;CREB3;ADCY7
prerank,Protein processing in endoplasmic reticulum,0.33871048318937974,1.6158987196156085,0.0,0.024495045518598872,0.62,53/171,26.98%,ATF4;SAR1A;MAN1A2;UBE2D3;CAPN1;BCAP31;DAD1;SKP1;NPLOC4;DNAJC3;WFS1;RRBP1;SSR4;EIF2AK1;DNAJC5;SEC63;EIF2AK2;UBQLN1;HSPH1;UGGT1;DDOST;BAX;UBE4B;PRKCSH;PDIA4;DERL1;SEC24C;RPN1;HSP90B1;LMAN2;UBE2J1;ERO1A;SEC62;STUB1;ERP29;MOGS;TRAF2;MAPK8;UBE2G1;UBE2J2;STT3B;STT3A;SEC31A;RAD23B;CAPN2;UBE2G2;UBXN4;VCP;BAG1;SEL1L;HSP90AA1;ATF6;UBXN6
prerank,MicroRNAs in cancer,0.34012342034747334,1.6142329151130768,0.0,0.024239888794446805,0.62,45/310,23.53%,IGF2BP1;CDK6;MCL1;CDC25B;FSCN1;VEGFA;TP53;NOTCH2;MTOR;ROCK1;HDAC2;MAPK1;MET;SIRT1;PLCG1;BMI1;EZR;MAPK3;CYP1B1;THBS1;TPM1;BCL2L2;PRKCA;RPTOR;HDAC1;EGFR;KRAS;CDKN2A;ERBB3;PIK3CB;CCNG1;PRKCG;MYC;PIK3CA;NRAS;STMN1;GRB2;CD44;EP300;CRK;SHC1;CDKN1A;ST14;SOS1;PIK3R3
prerank,cGMP-PKG signaling pathway,0.390969827890446,1.6096262252340796,0.018867924528301886,0.026031694568460533,0.64,27/167,22.99%,ATF4;AKT3;CALML5;GNA12;PPP1CA;ROCK1;MAPK1;PPP1R12A;MAPK3;ITPR3;CREB3L2;ATP2B1;ATP2B4;AKT1;GNAI2;CALM2;ADCY6;CALM1;CALM3;GNA13;CREB3;GTF2I;ADCY7;VDAC2;BAD;ATP1A1;AKT2
prerank,Pancreatic cancer,0.4015647534372636,1.5982598186704513,0.017543859649122806,0.028460555492915398,0.69,31/76,26.68%,CDK6;SMAD3;AKT3;VEGFA;TP53;MTOR;MAPK1;TGFBR2;MAPK3;RPS6KB1;CDC42;STAT1;RB1;AKT1;RAC1;BAX;EGFR;KRAS;CDKN2A;PIK3CB;PIK3CA;RALA;MAPK8;BAD;SMAD2;CDKN1A;AKT2;PIK3R3;CCND1;GADD45A;IKBKG
prerank,Lipid and atherosclerosis,0.3576523157209455,1.597717664321531,0.0,0.028173075134401104,0.69,45/215,27.11%,ATF4;RXRA;AKT3;CALML5;TP53;MAPK1;PLCG1;HSPD1;MAPK3;CDC42;GSK3B;PRKCA;AKT1;RAP1B;RAC1;IRF3;BAX;TANK;KRAS;CALM2;LYN;TAB2;PIK3CB;TNFRSF1A;HSP90B1;RAP1A;PIK3CA;NRAS;CALM1;ERO1A;CALM3;MAP2K4;TRAF2;MAP3K7;MAPK8;BAD;AKT2;PIK3R3;ROCK2;MAPK11;HSP90AA1;PTK2;IKBKG;ATF6;PDPK1
prerank,Central carbon metabolism in cancer,0.4061039882914441,1.5886780242761638,0.0,0.03003683241252302,0.7,18/70,18.66%,AKT3;SLC2A1;TP53;MTOR;MAPK1;MET;PFKP;MAPK3;AKT1;HK1;EGFR;KRAS;PIK3CB;PKM;MYC;PIK3CA;NRAS;PDHB
prerank,Measles,0.36323921352444344,1.5866282299953522,0.0,0.030556455560558183,0.7,28/139,24.81%,CDK6;AKT3;TP53;CDK2;TYK2;RACK1;EIF2AK1;CSNK2A2;EIF2AK2;STAT1;GSK3B;AKT1;IRF3;BAX;TAB2;PIK3CB;PIK3CA;TNFAIP3;EIF3H;IFNAR1;MAP3K7;MAPK8;BAD;CSNK2A1;AKT2;PIK3R3;MSN;CCND1
prerank,Endometrial cancer,0.4266950784969901,1.5649305100429787,0.017543859649122806,0.034625523250807616,0.71,24/58,27.11%,AKT3;TP53;MAPK1;MAPK3;GSK3B;AKT1;BAX;EGFR;KRAS;PIK3CB;CTNNB1;MYC;PIK3CA;NRAS;GRB2;BAD;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;CTNNA1;GADD45A;PDPK1
prerank,TGF-beta signaling pathway,0.3752325830159663,1.555526331283114,0.0,0.03637235120901913,0.72,11/94,7.96%,SMAD3;NBL1;PPP2R1A;SKP1;ROCK1;MAPK1;TGFBR2;SP1;MAPK3;RPS6KB1;THBS1
prerank,Apoptosis,0.3320683863853184,1.548950070362287,0.0,0.03824427626488825,0.75,34/142,24.31%,ATF4;LMNA;MCL1;AKT3;CAPN1;TP53;ACTG1;DFFA;MAPK1;BOK;MAPK3;BIRC2;ITPR3;PMAIP1;CTSD;AKT1;BIRC3;BECN1;BAX;KRAS;PIK3CB;TNFRSF1A;PIK3CA;ACTB;NRAS;TRAF2;MAPK8;DAB2IP;PARP4;BAD;AKT2;CAPN2;PIK3R3;TUBA1C
prerank,Colorectal cancer,0.3761938534402388,1.544778855925008,0.0,0.03945183116453834,0.79,32/86,25.67%,SMAD3;AKT3;MSH3;TP53;MTOR;MAPK1;TGFBR2;MAPK3;RPS6KB1;PMAIP1;GSK3B;AKT1;RAC1;BAX;EGFR;KRAS;PIK3CB;CTNNB1;MYC;PIK3CA;NRAS;GRB2;RALA;MAPK8;BAD;SMAD2;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;GADD45A
prerank,Non-alcoholic fatty liver disease,0.3401880951660315,1.5404248775651823,0.0,0.04032521042319854,0.81,43/155,25.02%,ATF4;RXRA;AKT3;NDUFB7;COX6A1;COX6B1;NDUFA4;NDUFC2;COX4I1;PRKAA1;UQCRB;CDC42;SDHA;GSK3B;AKT1;PRKAB1;RAC1;COX5A;NDUFB2;BAX;UQCRC2;NDUFS5;NDUFS2;PIK3CB;TNFRSF1A;COX7A2;PIK3CA;MLX;UQCR10;TRAF2;MAPK8;UQCR11;NDUFA5;NDUFC1;COX7C;ITCH;AKT2;UQCRQ;PIK3R3;NDUFA1;NDUFB6;NDUFA13;NDUFA10
prerank,Yersinia infection,0.3434794554756346,1.537488397653032,0.023255813953488372,0.04010257999001739,0.82,44/137,27.03%,WASL;AKT3;ACTG1;ROCK1;MAPK1;PLCG1;MAPK3;LIMK1;CDC42;GSK3B;SKAP2;WASF2;PKN2;AKT1;RPS6KA3;RAC1;IRF3;ARPC1B;ARPC3;TAB2;PIK3CB;PIK3CA;ACTB;MAP2K4;PXN;TRAF2;MAP3K7;MAPK8;CRK;AKT2;ACTR3C;PIK3R3;ARPC5;FN1;ARHGEF28;ACTR2;RHOG;ROCK2;MAPK11;PTK2;IKBKG;ARHGEF12;RPS6KA1;CRKL
prerank,Cellular senescence,0.3296683867969504,1.5305226781835723,0.0,0.04232907294601586,0.83,42/156,23.59%,HIPK2;CDK6;RBBP4;SMAD3;AKT3;CAPN1;CALML5;TP53;CDK2;PPP1CA;MTOR;MAPK1;TGFBR2;SIRT1;TRPM7;MAPK3;ITPR3;RB1;AKT1;NBN;KRAS;CDKN2A;CALM2;PIK3CB;MYC;PIK3CA;NRAS;CALM1;CALM3;ATR;IGFBP3;RAD50;RRAS2;VDAC2;SMAD2;CDKN1A;AKT2;RHEB;ZFP36L2;CAPN2;PIK3R3;SQSTM1
prerank,Phospholipase D signaling pathway,0.3556689003294591,1.5250675182412898,0.03278688524590164,0.04406048105678092,0.87,31/148,23.53%,AKT3;SHC3;GNA12;MTOR;MAPK1;PLCG1;GNAS;MAPK3;ARF1;PRKCA;AKT1;EGFR;KRAS;DNM2;ADCY6;PIK3CB;PIK3CA;DGKZ;NRAS;GNA13;DNM1;GRB2;RALA;ADCY7;RRAS2;AGPAT2;SHC1;SOS1;AKT2;RHEB;PIK3R3
prerank,Transcriptional misregulation in cancer,0.35576211865391427,1.5128177457006984,0.0,0.04891112570670582,0.88,23/192,15.62%,ELK4;DOT1L;SIX4;RXRA;FUS;TP53;HDAC2;MET;TGFBR2;SP1;BMI1;BIRC2;NCOR1;DDX5;EWSR1;BIRC3;NSD2;HDAC1;TAF15;BAX;KLF3;TCF3;MYC
prerank,Prolactin signaling pathway,0.39839169008989644,1.5112195034198848,0.01694915254237288,0.0489165323419467,0.88,19/70,26.20%,AKT3;SHC3;MAPK1;MAPK3;STAT1;GSK3B;AKT1;KRAS;PIK3CB;PIK3CA;NRAS;GRB2;MAPK8;SHC1;SOS1;AKT2;PIK3R3;CCND1;MAPK11
prerank,Hepatitis B,0.32338339454995596,1.492465397012222,0.017543859649122806,0.05437397547204177,0.92,40/162,23.53%,ATF4;SMAD3;AKT3;TP53;CDK2;YWHAZ;MAPK1;TGFBR2;TYK2;MAPK3;MAP3K1;CREB3L2;STAT1;RB1;PRKCA;AKT1;IRF3;BAX;KRAS;TAB2;PIK3CB;PRKCG;MYC;ATP6AP1;PIK3CA;NRAS;YWHAB;MAP2K4;IFNAR1;CREB3;GRB2;MAP3K7;MAPK8;EP300;DDX3X;BAD;CDKN1A;SOS1;AKT2;PIK3R3
prerank,Axon guidance,0.33234757094662915,1.4876856646435235,0.02040816326530612,0.05593750274237245,0.93,48/182,30.14%,PAK2;PTCH1;ROCK1;MAPK1;MET;PLCG1;MYL12B;CFL1;ABLIM3;SEMA3C;MAPK3;LIMK1;L1CAM;CDC42;PAK1;NTN1;GSK3B;SEMA3F;CDK5;PRKCA;GNAI2;RAC1;EPHB2;PRKCZ;KRAS;RASA1;PIK3CB;PIK3CA;NCK1;NRAS;ENAH;MYL12A;RYK;SEMA4C;RHOD;EPHA1;MYL5;PIK3R3;LIMK2;ROCK2;PTK2;ARHGEF12;PDPK1;SEMA4B;CAMK2G;RAC2;SEMA7A;PIK3R2
prerank,Cushing syndrome,0.35038371582473554,1.4842628868796333,0.016666666666666666,0.056604981074303555,0.93,26/155,19.17%,ATF4;CDK6;CDK2;KMT2D;MAPK1;SP1;GNAS;PRKACB;MAPK3;DVL3;ITPR3;CREB3L2;SCARB1;GSK3B;RB1;GNAI2;RAP1B;EGFR;CDKN2A;ADCY6;CTNNB1;RAP1A;PRKACA;WNT9A;CREB3;ADCY7
prerank,Human immunodeficiency virus 1 infection,0.3090017523757472,1.482861275193146,0.0,0.056399785657532474,0.93,50/212,23.53%,PAK2;AKT3;CALML5;GNB1;SKP1;MTOR;MAPK1;PLCG1;GNG5;CFL1;MAPK3;ITPR3;RPS6KB1;LIMK1;B2M;PAK1;AP1S1;AP1G2;PRKCA;AKT1;GNB5;GNAI2;RAC1;ELOB;IRF3;WEE1;BAX;KRAS;CALM2;TAB2;PIK3CB;PRKCG;TNFRSF1A;PIK3CA;NRAS;CALM1;CALM3;ATR;CUL5;GNG12;PXN;TRAF2;MAP3K7;MAPK8;AP1B1;BAD;CRK;GNB2;AKT2;PIK3R3
prerank,Prostate cancer,0.3646388496356727,1.478919406806752,0.037037037037037035,0.05762086551284494,0.93,31/97,27.11%,ATF4;AKT3;TP53;CDK2;MTOR;MAPK1;MAPK3;CREB3L2;GSK3B;RB1;AKT1;EGFR;KRAS;PIK3CB;CTNNB1;HSP90B1;PIK3CA;NRAS;CREB3;GRB2;EP300;IGF1R;BAD;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;HSP90AA1;IKBKG;PDPK1
prerank,Metabolism of xenobiotics by cytochrome P450,0.4752551407476479,1.478255901415123,0.061224489795918366,0.05712837948282062,0.93,7/76,17.88%,MGST1;ALDH3A1;CYP1B1;UGT1A6;AKR1C1;GSTM3;UGT1A3
prerank,mTOR signaling pathway,0.3159314465668879,1.4782397461639551,0.018518518518518517,0.056644240673644174,0.93,38/154,23.53%,AKT3;AKT1S1;MTOR;MAPK1;PRKAA1;RICTOR;MAPK3;DVL3;MIOS;RPS6KB1;GSK3B;ATP6V1F;LPIN2;PRKCA;AKT1;RPS6KA3;RPTOR;EIF4B;STRADB;KRAS;EIF4E2;PIK3CB;PRKCG;TNFRSF1A;GRB10;RPS6;PIK3CA;NRAS;WNT9A;GRB2;MLST8;LAMTOR3;IGF1R;DVL1;SOS1;AKT2;RHEB;PIK3R3
prerank,Fc epsilon RI signaling pathway,0.38633226590429826,1.4779959008470558,0.02,0.056306925660191826,0.93,22/68,30.14%,AKT3;MAPK1;PLCG1;MAPK3;PRKCA;AKT1;RAC1;KRAS;LYN;PIK3CB;PIK3CA;NRAS;MAP2K4;GRB2;MAPK8;SOS1;AKT2;PIK3R3;MAPK11;PDPK1;RAC2;PIK3R2
prerank,Salmonella infection,0.28809138943622237,1.4778746264256335,0.0,0.05583770127969023,0.93,74/249,28.19%,PIK3C2A;WASL;AKT3;FLNA;KIF5B;ACTG1;SKP1;FLNB;DYNLL2;MAPK1;RPS3;MYL12B;S100A10;CYFIP1;MAPK3;ARF1;BIRC2;DYNC1H1;FLNC;KPNA1;CDC42;PAK1;PIK3C3;ANXA2;AKT1;KPNA4;BIRC3;RAC1;KPNA3;BAX;NCKAP1;ARPC1B;DNM2;ARPC3;TAB2;PIK3CB;TNFRSF1A;CTNNB1;HSP90B1;MYC;PIK3CA;ACTB;MAP2K4;DYNC1I2;RIPK2;RALA;TRAF2;MAP3K7;MAPK8;DYNLT1;MYL12A;CASP4;EXOC5;MYL5;DCTN3;AKT2;ACTR3C;VPS41;ARPC5;DYNC1LI2;TUBA1C;ACTR2;RHOG;ROCK2;DCTN2;MAPK11;TAB3;HSP90AA1;IKBKG;GCC2;PIK3C2B;RAB7A;AHNAK;PLEKHM2
prerank,Neutrophil extracellular trap formation,0.36070005465224203,1.468801927161827,0.022222222222222223,0.05919528320331937,0.93,22/189,23.53%,AKT3;ACTG1;MTOR;HDAC2;MAPK1;PLCG1;MAPK3;CLCN3;PRKCA;AKT1;RAC1;HDAC1;PIK3CB;PRKCG;PIK3CA;ACTB;C3;MAP3K7;VDAC2;CASP4;AKT2;PIK3R3
prerank,Fc gamma R-mediated phagocytosis,0.35401699583792945,1.4676062374996128,0.06,0.05898062930940388,0.93,29/97,24.83%,AKT3;MAPK1;PLCG1;CFL1;MAPK3;RPS6KB1;LIMK1;CDC42;PAK1;INPPL1;WASF2;PRKCA;AKT1;RAC1;ARPC1B;DNM2;ARPC3;LYN;PIK3CB;PRKCG;PIK3CA;MYO10;CRK;AKT2;ACTR3C;PIK3R3;ARPC5;LIMK2;ACTR2
prerank,Staphylococcus aureus infection,0.4933637106344973,1.4648635485207455,0.125,0.060379588071273825,0.94,7/95,21.28%,KRT17;CFD;KRT13;HLA-DQB1;C3;C1S;KRT19
prerank,Influenza A,0.3280081910458442,1.4559788207178606,0.03636363636363636,0.06441787880034182,0.94,26/172,18.33%,CDK6;AKT3;RAB11A;PABPN1;ACTG1;MAPK1;DNAJC3;TYK2;KPNA6;BCL2L2-PABPN1;MAPK3;KPNA1;XPO1;EIF2AK2;STAT1;PRKCA;AKT1;HNRNPUL1;IRF3;BAX;PIK3CB;TNFRSF1A;PIK3CA;ACTB;HLA-DQB1;IFNAR1
prerank,Choline metabolism in cancer,0.3433253452139551,1.4469429917003682,0.05555555555555555,0.06865561694290977,0.96,26/98,23.53%,AKT3;MTOR;MAPK1;CHKA;SP1;PLCG1;MAPK3;RPS6KB1;WASF2;PRKCA;AKT1;SLC44A1;RAC1;EGFR;KRAS;PIK3CB;PRKCG;PIK3CA;DGKZ;NRAS;GRB2;MAPK8;SOS1;AKT2;RHEB;PIK3R3
prerank,Nucleotide excision repair,-0.3674346510843028,-1.4450746001512236,0.04878048780487805,0.3099863803877584,0.99,18/47,30.00%,GTF2H4;PCNA;RBX1;POLE;ERCC2;ERCC5;POLD1;RFC5;POLE2;POLD3;RFC2;RFC3;RFC4;DDB1;ERCC6;CDK7;POLE3;XPC
prerank,Dilated cardiomyopathy,0.41397649026268635,1.4342971729291463,0.04081632653061224,0.07413591115248573,0.97,14/96,19.17%,ITGA3;LMNA;ACTG1;GNAS;PRKACB;TPM1;CACNG6;TPM3;ADCY6;TPM4;PRKACA;ACTB;TPM2;ADCY7
prerank,Gap junction,0.3699527424007545,1.432410306503683,0.02,0.07446181955687328,0.97,17/88,19.17%,MAP3K2;MAPK1;GNAS;PRKACB;MAPK3;ITPR3;CSNK1D;PRKCA;GNAI2;EGFR;KRAS;ADCY6;PRKCG;PRKACA;NRAS;GRB2;ADCY7
prerank,Cocaine addiction,0.4729496584953846,1.4285889820087259,0.04081632653061224,0.07568518469329934,0.98,8/49,18.55%,ATF4;GNAS;PRKACB;CREB3L2;CDK5;GNAI2;PRKACA;CREB3
prerank,Protein digestion and absorption,0.42234484384728266,1.4279559911397983,0.0392156862745098,0.07522641391329558,0.98,9/103,22.01%,COL17A1;SLC38A2;COL4A5;PRCP;COL7A1;COL6A1;COL6A2;KCNN4;ATP1A1
prerank,Oxidative phosphorylation,0.31153002062207324,1.424541473741809,0.0,0.07680593241579217,0.98,33/133,25.62%,ATP5PD;NDUFB7;COX6A1;COX6B1;ATP5MF;ATP6V0C;NDUFA4;NDUFC2;COX4I1;UQCRB;SDHA;ATP6V1F;COX5A;NDUFB2;UQCRC2;NDUFS5;ATP5PB;NDUFS2;COX7A2;ATP6V0A1;ATP6AP1;TCIRG1;UQCR10;UQCR11;NDUFA5;NDUFC1;COX7C;UQCRQ;NDUFA1;NDUFB6;NDUFA13;NDUFA10;ATP5F1B
prerank,JAK-STAT signaling pathway,0.33563796763394854,1.4213383578819008,0.03225806451612903,0.07848731898750877,0.98,23/162,24.95%,OSMR;MCL1;AKT3;MTOR;TYK2;STAT1;AKT1;EGFR;IL6ST;PIK3CB;MYC;PIK3CA;PIAS1;IFNAR1;GRB2;EP300;IL11;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;PIM1
prerank,Insulin resistance,0.3568979236633747,1.4209331097176268,0.02040816326530612,0.07814277496597938,0.98,23/108,19.87%,AKT3;PYGL;SLC2A1;PPP1CA;OGT;MTOR;GFPT1;PRKAA1;PTPRF;RPS6KB1;CREB3L2;GSK3B;AKT1;RPS6KA3;PRKAB1;PRKCZ;PIK3CB;TNFRSF1A;PIK3CA;GYS1;MLX;CREB3;MAPK8
prerank,Collecting duct acid secretion,0.4390566067858094,1.41907059402106,0.1,0.07805158881053036,0.98,5/27,17.70%,ATP6V0C;ATP6V1F;CA2;ATP6V0A1;TCIRG1
prerank,Signaling pathways regulating pluripotency of stem cells,0.3253475696221847,1.4160881085310169,0.06557377049180328,0.07882390004926494,0.98,26/143,23.53%,SMAD3;AKT3;MAPK1;BMI1;MAPK3;DVL3;GSK3B;AKT1;KRAS;IL6ST;TCF3;PIK3CB;CTNNB1;MYC;PIK3CA;NRAS;WNT9A;GRB2;IGF1R;DVL1;PCGF3;RIF1;SMAD2;INHBA;AKT2;PIK3R3
prerank,Autophagy,0.2886263749630106,1.3993627747145454,0.022727272727272728,0.08985377217421416,0.98,50/137,30.53%,AKT3;AKT1S1;RAB1A;MTOR;MAPK1;PRKAA1;PRKACB;MAPK3;MTMR4;RPS6KB1;DAPK1;PIK3C3;CTSD;SH3GLB1;AKT1;RPTOR;GABARAP;ATG5;BECN1;STX17;TANK;KRAS;VMP1;PIK3CB;PIK3CA;PRKACA;NRAS;MLST8;RRAS2;MAP3K7;MAPK8;IGF1R;BAD;AKT2;RHEB;PIK3R3;SQSTM1;WIPI2;WDR41;ATG13;PDPK1;RAB7A;STK11;EIF2S1;PIK3R4;ATG4B;ATG12;PIK3R2;ATG16L1;IRS2
prerank,Ovarian steroidogenesis,0.4615253505364997,1.3955571031438918,0.09433962264150944,0.09089199853337,0.98,9/51,20.46%,GNAS;PRKACB;CYP1B1;SCARB1;ADCY6;PRKACA;AKR1C3;ADCY7;IGF1R
prerank,Pathways of neurodegeneration,0.25368154213420957,1.3785925610309178,0.015151515151515152,0.10215462374997804,0.99,99/475,25.83%,ATF4;VAPB;ATP5PD;GPX2;NDUFB7;KIF5B;COX6A1;CAPN1;HTT;FUS;ATXN2L;CALML5;COX6B1;CSNK1E;RAB1A;MTOR;MAPK1;UCHL1;NDUFA4;NDUFC2;COX4I1;PLCG1;MFN2;MAPK3;DVL3;UQCRB;APP;ITPR3;CSNK2A2;PIK3C3;SDHA;PARK7;GSK3B;ATXN1L;CSF1;CDK5;PRKCA;RAC1;GABARAP;COX5A;PSMA5;NDUFB2;BECN1;RPS27A;PSMD9;BAX;UQCRC2;TANK;KRAS;DERL1;NDUFS5;CALM2;ATP5PB;GPX8;NDUFS2;PRKCG;TNFRSF1A;CTNNB1;COX7A2;GPX3;UBB;UBE2J1;UBE2L3;NRAS;CALM1;CALM3;WNT9A;CSNK1A1;TARDBP;PSMD2;UQCR10;TRAF2;VDAC2;MAPK8;UBE2G1;DVL1;UQCR11;UBE2J2;NDUFA5;NDUFC1;BAD;CSNK2A1;COX7C;DCTN3;UQCRQ;CAPN2;UBE2G2;SQSTM1;NDUFA1;NDUFB6;TUBA1C;VCP;NDUFA13;WIPI2;NDUFA10;PSMA2;ATP5F1B;WDR41;DCTN2
prerank,Legionellosis,0.36567328978556046,1.3755738528342987,0.043478260869565216,0.10380622126958904,1.0,14/57,32.79%,SAR1A;RAB1A;HSPD1;ARF1;EEF1G;C3;HSF1;EEF1A1;VCP;NFKB2;HBS1L;CYCS;RAB1B;SAR1B
prerank,Type II diabetes mellitus,0.47932509081328345,1.3744571414556157,0.1,0.10400927027184034,1.0,10/46,23.53%,MTOR;MAPK1;MAPK3;HK1;PRKCZ;PIK3CB;PKM;PIK3CA;MAPK8;PIK3R3
prerank,NOD-like receptor signaling pathway,0.2909598919944533,1.373532217999509,0.02040816326530612,0.10385576670107056,1.0,35/181,26.68%,MAPK1;MFN2;TYK2;PANX1;TRPM7;MAPK3;BIRC2;ITPR3;STAT1;SUGT1;PKN2;BIRC3;GABARAP;ATG5;IRF3;TANK;TAB2;TRIP6;NAMPT;NEK7;TNFAIP3;RIPK2;IFNAR1;TRAF2;YWHAE;MAP3K7;VDAC2;MAPK8;CASP4;TXNIP;TP53BP1;MAPK11;TAB3;HSP90AA1;IKBKG
prerank,T cell receptor signaling pathway,0.34313004937491653,1.3680388718113323,0.061224489795918366,0.10674768591778112,1.0,26/104,27.56%,PAK2;AKT3;CARD11;MAPK1;PLCG1;MAPK3;CDC42;PAK1;DLG1;GSK3B;AKT1;KRAS;PIK3CB;PIK3CA;NCK1;NRAS;GRB2;MAP3K7;MAPK8;SOS1;AKT2;PIK3R3;MAPK11;IKBKG;PDPK1;BCL10
prerank,Glutathione metabolism,0.35544395540682,1.364526640080118,0.09259259259259259,0.10901775577676286,1.0,8/57,15.40%,MGST1;GPX2;PGD;PRDX6;GSTM3;GPX8;ODC1;GPX3
prerank,Renin secretion,0.4530360242586421,1.3588265424588482,0.0625,0.11252559595101033,1.0,10/69,17.09%,CALML5;GNAS;PRKACB;ITPR3;GNAI2;CALM2;ADCY6;PRKACA;CALM1;CALM3
prerank,Adipocytokine signaling pathway,0.35765298873038415,1.3574097769434224,0.09433962264150944,0.11289026223418488,1.0,12/69,19.87%,RXRA;AKT3;SLC2A1;MTOR;PRKAA1;AKT1;PRKAB1;ACSL1;ACSL4;TNFRSF1A;TRAF2;MAPK8
prerank,Viral myocarditis,0.4026415603837782,1.3567378469509166,0.07142857142857142,0.11256698467595781,1.0,11/60,24.81%,ABL2;ACTG1;EIF4G2;RAC1;EIF4G3;CD55;ACTB;HLA-DQB1;CAV1;EIF4G1;CCND1
prerank,Steroid biosynthesis,0.4525331923054582,1.3518883566181703,0.1,0.11405676616075466,1.0,5/20,14.65%,DHCR24;LSS;LIPA;DHCR7;SC5D
prerank,VEGF signaling pathway,0.35824190700934977,1.3513201166159987,0.05660377358490566,0.1137299515357921,1.0,21/59,26.59%,AKT3;VEGFA;MAPK1;PLCG1;MAPK3;CDC42;PRKCA;AKT1;RAC1;KRAS;PIK3CB;PRKCG;PIK3CA;HSPB1;NRAS;PXN;BAD;AKT2;PIK3R3;MAPK11;PTK2
prerank,Parkinson disease,0.2638182024176525,1.34816793915825,0.06666666666666667,0.1151917429541739,1.0,58/249,25.62%,ATF4;ATP5PD;NDUFB7;KIF5B;COX6A1;CALML5;COX6B1;TP53;UCHL1;NDUFA4;NDUFC2;COX4I1;PLCG1;GNAS;MFN2;PRKACB;UQCRB;ITPR3;SDHA;PARK7;GNAI2;COX5A;PSMA5;NDUFB2;RPS27A;PSMD9;BAX;UQCRC2;NDUFS5;CALM2;ATP5PB;NDUFS2;COX7A2;UBB;PRKACA;UBE2J1;UBE2L3;CALM1;CALM3;PSMD2;UQCR10;VDAC2;MAPK8;UBE2G1;UQCR11;UBE2J2;NDUFA5;NDUFC1;COX7C;UQCRQ;UBE2G2;NDUFA1;NDUFB6;TUBA1C;NDUFA13;NDUFA10;PSMA2;ATP5F1B
prerank,FoxO signaling pathway,0.3113893598077242,1.3479159779167096,0.05660377358490566,0.11475093435863207,1.0,38/131,30.53%,SMAD3;AKT3;CDK2;CSNK1E;PRMT1;MAPK1;TGFBR2;SIRT1;PRKAA1;MAPK3;STK4;AKT1;PRKAB1;GABARAP;EGFR;KRAS;PIK3CB;PIK3CA;NRAS;SETD7;GRB2;MAPK8;EP300;IGF1R;CDKN1A;SOS1;AKT2;PIK3R3;CCND1;NLK;GADD45A;MAPK11;PDPK1;KLF2;STK11;ATG12;PIK3R2;IRS2
prerank,Cortisol synthesis and secretion,0.3785834639734443,1.3438028262129293,0.06349206349206349,0.11640647872692071,1.0,11/65,19.17%,ATF4;SP1;GNAS;PRKACB;ITPR3;CREB3L2;SCARB1;ADCY6;PRKACA;CREB3;ADCY7
prerank,Notch signaling pathway,0.35687013822652197,1.3342522304767486,0.07692307692307693,0.12175617243123006,1.0,14/59,25.42%,NCOR2;MFNG;NOTCH2;HDAC2;DVL3;ATXN1L;HDAC1;CTBP1;EP300;DVL1;NUMBL;RFNG;DTX3L;RBPJ
prerank,Epithelial cell signaling in Helicobacter pylori infection,0.3320606787141085,1.3232935348602977,0.058823529411764705,0.1290984446880056,1.0,15/70,19.87%,ADAM10;ATP6V0C;MET;PLCG1;CDC42;PAK1;ATP6V1F;RAC1;EGFR;LYN;ATP6V0A1;ATP6AP1;MAP2K4;TCIRG1;MAPK8
prerank,Calcium signaling pathway,0.3164898415150777,1.2976559228247555,0.07547169811320754,0.1510147431499398,1.0,22/240,19.65%,VEGFA;CALML5;MET;PLCG1;GNAS;P2RX5;PRKACB;ITPR3;PHKB;ATP2B1;ATP2B4;PRKCA;EGFR;ERBB3;CALM2;PRKCG;PRKACA;CALM1;CALM3;ADCY7;VEGFC;VDAC2
prerank,Mismatch repair,-0.39772235117457155,-1.2931018844477278,0.20930232558139536,0.6879186027880146,1.0,10/23,24.98%,PCNA;MSH2;POLD1;RFC5;POLD3;RFC2;MSH6;RFC3;EXO1;RFC4
prerank,AMPK signaling pathway,0.30033509930257646,1.2925145413414123,0.06896551724137931,0.15517815517815517,1.0,33/120,30.53%,PPP2R5E;AKT3;AKT1S1;PPP2R1A;MTOR;SIRT1;PFKP;PRKAA1;RPS6KB1;CREB3L2;AKT1;RPTOR;PRKAB1;STRADB;PIK3CB;PIK3CA;GYS1;FASN;CREB3;MAP3K7;IGF1R;AKT2;RHEB;PIK3R3;CCND1;PPP2R5C;PDPK1;RAB10;STK11;SCD;PIK3R2;TBC1D1;IRS2
prerank,NF-kappa B signaling pathway,0.33492149686357725,1.2834221497664662,0.06818181818181818,0.16386630656814224,1.0,20/104,27.56%,CARD11;PLCG1;BIRC2;LTBR;CSNK2A2;BIRC3;LYN;TAB2;TNFRSF1A;TNFAIP3;CARD10;TRAF2;MAP3K7;CSNK2A1;NFKB2;GADD45A;TRIM25;TAB3;IKBKG;BCL10
prerank,Vasopressin-regulated water reabsorption,0.3717402449715131,1.2797802313038467,0.1568627450980392,0.16683602674890394,1.0,11/44,20.07%,RAB11A;DYNLL2;GNAS;PRKACB;DYNC1H1;CREB3L2;ADCY6;PRKACA;DYNC1I2;CREB3;VAMP2
prerank,Chagas disease,0.30678727949253803,1.269215110999733,0.1509433962264151,0.176390441619002,1.0,21/102,28.10%,AKT3;PPP2R1A;MAPK1;TGFBR2;GNAS;MAPK3;AKT1;GNAI2;PIK3CB;TNFRSF1A;PIK3CA;MAP2K4;C3;MAPK8;SMAD2;AKT2;PIK3R3;MAPK11;IKBKG;IFNGR1;GNA11
prerank,Human T-cell leukemia virus 1 infection,0.26486670140551105,1.2666668921258293,0.11764705882352941,0.17809430819081842,1.0,51/219,25.78%,ATF4;SMAD3;ELK4;AKT3;SLC2A1;TP53;CDK2;MAPK1;TGFBR2;RANBP3;PRKACB;MAPK3;LTBR;XPO1;MAP3K1;B2M;CREB3L2;DLG1;RB1;AKT1;BAX;KRAS;CDKN2A;ADCY6;TCF3;PIK3CB;TNFRSF1A;MYC;PIK3CA;PRKACA;NRAS;ATR;MAP2K4;HLA-DQB1;CREB3;ADCY7;VDAC2;MAPK8;EP300;TSPO;SMAD2;CDKN1A;CDC16;AKT2;ANAPC1;PIK3R3;MAD1L1;CCND1;FDPS;NFKB2;ANAPC2
prerank,Carbohydrate digestion and absorption,0.4288671573575024,1.2647895703625236,0.17307692307692307,0.17842737893816807,1.0,8/47,23.53%,AKT3;AKT1;HK1;PIK3CB;PIK3CA;ATP1A1;AKT2;PIK3R3
prerank,Progesterone-mediated oocyte maturation,0.315936501559716,1.2563715461589946,0.1,0.18690501487462816,1.0,28/100,26.87%,CDC25B;AKT3;CDK2;FZR1;MAPK1;PRKACB;MAPK3;AKT1;RPS6KA3;GNAI2;KRAS;ADCY6;PIK3CB;ANAPC13;PIK3CA;PRKACA;ADCY7;MAPK8;IGF1R;CDC16;AKT2;ANAPC1;PIK3R3;MAD1L1;ANAPC2;MAPK11;HSP90AA1;RPS6KA1
prerank,Glycolysis / Gluconeogenesis,0.3123485943417769,1.2559566326830418,0.11627906976744186,0.18605163752893755,1.0,11/67,18.66%,GPI;PFKP;ALDH3A1;DLD;ALDH3A2;HK1;ALDH1B1;ALDOA;PKM;ENO1;PDHB
prerank,Alzheimer disease,0.23586458523521311,1.252038051130738,0.04838709677419355,0.19050629701335656,1.0,74/369,25.62%,ATF4;ATP5PD;AKT3;NDUFB7;KIF5B;COX6A1;CAPN1;CALML5;COX6B1;CSNK1E;MTOR;ADAM10;MAPK1;NDUFA4;NDUFC2;COX4I1;MAPK3;DVL3;UQCRB;APP;ITPR3;CSNK2A2;PIK3C3;EIF2AK2;SDHA;GSK3B;CSF1;CDK5;AKT1;COX5A;PSMA5;NDUFB2;BECN1;PSMD9;UQCRC2;KRAS;NDUFS5;CALM2;ATP5PB;NDUFS2;PIK3CB;TNFRSF1A;CTNNB1;COX7A2;PIK3CA;NRAS;CALM1;CALM3;WNT9A;CSNK1A1;PSMD2;UQCR10;TRAF2;VDAC2;MAPK8;DVL1;UQCR11;NDUFA5;NDUFC1;BAD;CSNK2A1;COX7C;AKT2;UQCRQ;CAPN2;PIK3R3;NDUFA1;NDUFB6;TUBA1C;NDUFA13;WIPI2;NDUFA10;PSMA2;ATP5F1B
prerank,RNA transport,0.2571611248038786,1.250957914976975,0.12962962962962962,0.1902487969498104,1.0,37/186,18.71%,TPR;RANGAP1;RANBP2;PABPC1L;CASC3;FUS;RNPS1;EIF3CL;CLNS1A;NUP153;UPF2;CYFIP1;FXR1;XPO1;EIF4A1;EIF3B;EIF3A;EIF4EBP2;EIF3C;NUP160;EIF4G2;EIF2S3;PHAX;EIF4B;PNN;EIF4E2;EIF4G3;EIF3I;PABPC1;EIF4A3;SUMO1;THOC2;PABPC4;TARDBP;EIF3E;EIF3H;MAGOH
prerank,Wnt signaling pathway,0.2700151745983909,1.250412352085597,0.0967741935483871,0.18969253919058526,1.0,28/166,21.77%,SMAD3;TP53;CSNK1E;SKP1;PRKACB;DVL3;PORCN;CSNK2A2;GSK3B;PRKCA;RAC1;PRKCG;CTNNB1;CTBP1;MYC;PRKACA;TBL1XR1;WNT9A;CSNK1A1;DAAM1;MAP3K7;MAPK8;EP300;RYK;DVL1;CBY1;CTNNBIP1;CSNK2A1
prerank,"Valine, leucine and isoleucine degradation",0.34279178692100293,1.2473807902131016,0.1875,0.19204368375639091,1.0,11/48,16.09%,ACAA1;MCCC1;ABAT;DLD;ALDH3A2;BCAT1;ACAT2;MCCC2;HIBADH;ALDH1B1;HADHA
prerank,Huntington disease,0.24159182201395338,1.2387347518992389,0.05172413793103448,0.20092823482625785,1.0,66/306,25.91%,CLTB;ATP5PD;GPX2;NDUFB7;KIF5B;COX6A1;HTT;COX6B1;TP53;MTOR;HDAC2;NDUFA4;NDUFC2;SP1;COX4I1;UQCRB;POLR2F;CREB3L2;PIK3C3;SDHA;RCOR1;POLR2H;HDAC1;POLR2J3;COX5A;PSMA5;NDUFB2;BECN1;AP2S1;PSMD9;BAX;UQCRC2;NDUFS5;ATP5PB;GPX8;NDUFS2;COX7A2;GPX3;CLTC;AP2M1;POLR2J;POLR2I;POLR2L;PSMD2;CREB3;UQCR10;TRAF2;VDAC2;MAPK8;EP300;UQCR11;NDUFA5;NDUFC1;COX7C;DCTN3;UQCRQ;NDUFA1;NDUFB6;TUBA1C;NDUFA13;WIPI2;NDUFA10;PSMA2;ATP5F1B;DCTN2;SIN3A
prerank,Toxoplasmosis,0.29065025468682393,1.2363152163949476,0.13636363636363635,0.20318394235752885,1.0,25/112,27.49%,LAMA5;AKT3;LAMB1;MAPK1;TYK2;MAPK3;BIRC2;STAT1;AKT1;BIRC3;GNAI2;TAB2;TNFRSF1A;LAMC2;LAMB2;HLA-DQB1;MAP3K7;MAPK8;BAD;AKT2;LAMA4;MAPK11;IKBKG;PDPK1;IFNGR1
prerank,B cell receptor signaling pathway,0.32728352428202717,1.2343837027971758,0.1568627450980392,0.20472513980801274,1.0,17/81,23.53%,AKT3;CARD11;MAPK1;MAPK3;GSK3B;INPPL1;AKT1;RAC1;KRAS;LYN;PIK3CB;PIK3CA;NRAS;GRB2;SOS1;AKT2;PIK3R3
prerank,Acute myeloid leukemia,0.3204351246059974,1.2312955089195152,0.16071428571428573,0.20781058382810647,1.0,19/67,26.68%,AKT3;MTOR;MAPK1;MAPK3;RPS6KB1;AKT1;KRAS;PIK3CB;MYC;PIK3CA;NRAS;GRB2;BAD;SOS1;AKT2;PIK3R3;CCND1;PIM1;IKBKG
prerank,Homologous recombination,-0.34670697261217354,-1.2273865633381793,0.09090909090909091,0.834561768947284,1.0,10/41,23.36%,UIMC1;RAD51;XRCC2;RAD54L;POLD1;POLD3;XRCC3;RAD52;BRCA1;TOP3A
prerank,Complement and coagulation cascades,0.37479301836987244,1.2255558252171674,0.19148936170212766,0.21357799388348625,1.0,7/85,19.84%,CFD;CD59;F3;CD55;CLU;C3;C1S
prerank,Spliceosome,0.26253255855036745,1.2210583464914015,0.14035087719298245,0.21734768521625167,1.0,42/150,26.25%,SRSF6;SRSF10;U2SURP;FUS;HNRNPU;PRPF38B;TRA2A;SRSF2;DHX15;RBM25;PRPF3;SRSF5;DDX5;DDX23;SRSF3;SF3B1;CWC15;U2AF2;DDX42;EIF4A3;HNRNPA3;THOC2;CRNKL1;TRA2B;MAGOH;HNRNPC;SNRPD2;RP9;SNRPD3;PRPF40A;SNRNP200;CDC5L;LSM7;SNRNP70;SRSF1;DDX46;ACIN1;AQR;HNRNPA1;SF3A2;RBM8A;SF3A1
prerank,Starch and sucrose metabolism,0.40595874110996866,1.2166805110959367,0.30612244897959184,0.22145735116312015,1.0,6/36,16.86%,PYGL;GPI;AGL;HK1;UGP2;GYS1
prerank,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.30260263447663077,1.2038350115450458,0.18867924528301888,0.23400987711338045,1.0,16/89,16.64%,EML4;AKT3;MTOR;MAPK1;PLCG1;MAPK3;RPS6KB1;CSNK2A2;STAT1;AKT1;BATF;EGFR;KRAS;PIK3CB;PIK3CA;NRAS
prerank,PPAR signaling pathway,-0.32570102872154244,-1.203628219632686,0.27450980392156865,0.8233570627417767,1.0,13/74,24.06%,CPT2;PPARD;EHHADH;NR1H3;FABP5;PPARG;SCP2;SLC27A4;HMGCS1;SLC27A1;SCD5;ACSL5;ACOX3
prerank,Ribosome biogenesis in eukaryotes,-0.273744591924767,-1.2015674475008686,0.1794871794871795,0.7303517064572985,1.0,24/108,27.42%,NXT1;PWP2;RPP25;NOP58;RIOK1;UTP4;WDR43;TBL3;UTP18;RBM28;DKC1;UTP14A;POP7;NOL6;NAT10;POP5;RCL1;WDR3;RPP30;TCOF1;NVL;GNL3L;NOP10;GTPBP4
prerank,TNF signaling pathway,0.2778201400800776,1.2007423554553722,0.18518518518518517,0.2364589592156748,1.0,29/112,27.34%,ATF4;AKT3;MAPK1;MAPK3;BIRC2;CREB3L2;CSF1;AKT1;BIRC3;TAB2;PIK3CB;TNFRSF1A;PIK3CA;TNFAIP3;MAP2K4;CREB3;TRAF2;VEGFC;MAP3K7;MAPK8;DAB2IP;ITCH;AKT2;PIK3R3;PGAM5;MAPK11;TAB3;IKBKG;MMP14
prerank,Fanconi anemia pathway,-0.3257901053151053,-1.2001184017122184,0.16326530612244897,0.6550766437002618,1.0,13/54,23.36%,RMI2;RAD51;USP1;TELO2;HES1;FANCF;FANCD2;FANCI;FANCC;UBE2T;BRCA1;FANCA;TOP3A
prerank,Proteasome,-0.295039896269753,-1.1982568820674167,0.16666666666666666,0.5969716391603909,1.0,15/46,29.44%,PSMD13;PSMD1;PSMD6;PSMB8;PSMD14;PSMC4;POMP;PSMD11;PSMB2;PSMA3;PSMB7;PSMB1;PSMA1;PSMD3;PSME1
prerank,Pyruvate metabolism,0.3044399501982408,1.1975864748281608,0.23404255319148937,0.23916297330661973,1.0,9/47,21.59%,ACYP1;DLD;ALDH3A2;ACAT2;ALDH1B1;PKM;PDHB;ME3;MDH2
prerank,Pyrimidine metabolism,-0.31557691054351095,-1.1943820830511451,0.2222222222222222,0.5539977567697485,1.0,11/56,20.94%,CTPS2;DCTPP1;UCKL1;RRM1;PNP;NME7;NME1;UMPS;CAD;DPYD;UCK2
prerank,Phosphatidylinositol signaling system,0.2837257278419384,1.193870392780936,0.21052631578947367,0.24230511661450885,1.0,16/97,17.09%,PIK3C2A;CALML5;PLCG1;MTMR4;ITPR3;PIK3C3;INPPL1;ITPK1;PRKCA;CALM2;PIK3CB;PRKCG;PIK3CA;DGKZ;CALM1;CALM3
prerank,Tuberculosis,0.26450160584688764,1.1912928605314834,0.1836734693877551,0.24438609844546727,1.0,25/180,20.26%,AKT3;CALML5;ATP6V0C;MAPK1;HSPD1;MAPK3;NFYA;CD74;PIK3C3;STAT1;CTSD;AKT1;BAX;CALM2;TNFRSF1A;ATP6V0A1;ATP6AP1;CALM1;CALM3;TCIRG1;RIPK2;HLA-DQB1;C3;MAPK8;EP300
prerank,Natural killer cell mediated cytotoxicity,0.3017771399732661,1.191078776336411,0.18518518518518517,0.2431058605557333,1.0,17/131,23.53%,SHC3;MAPK1;PLCG1;MAPK3;PAK1;PRKCA;RAC1;KRAS;PIK3CB;PRKCG;PIK3CA;NRAS;IFNAR1;GRB2;SHC1;SOS1;PIK3R3
prerank,Cysteine and methionine metabolism,-0.3027197781359633,-1.1811625129603371,0.23076923076923078,0.540217913795866,1.0,7/50,11.90%,AMD1;GSS;PSAT1;ENOPH1;GOT1;GOT2;DNMT1
prerank,Osteoclast differentiation,0.29063214606974924,1.1748553606840584,0.16981132075471697,0.2637834659347669,1.0,27/127,27.49%,AKT3;MAPK1;TGFBR2;TYK2;MAPK3;STAT1;CSF1;AKT1;RAC1;TAB2;PIK3CB;TNFRSF1A;PIK3CA;IFNAR1;GRB2;TRAF2;MAP3K7;FOSL2;MAPK8;AKT2;PIK3R3;SQSTM1;NFKB2;MAPK11;JUND;IKBKG;IFNGR1
prerank,"Alanine, aspartate and glutamate metabolism",0.38475092468938366,1.1707838928930627,0.23529411764705882,0.26827769120586803,1.0,5/37,10.09%,RIMKLB;CPS1;GFPT1;ABAT;ASS1
prerank,Th17 cell differentiation,0.29885262003755975,1.169612749654518,0.20754716981132076,0.26816320844280916,1.0,9/107,8.33%,SMAD3;RXRA;MTOR;MAPK1;TGFBR2;PLCG1;TYK2;MAPK3;STAT1
prerank,Rheumatoid arthritis,0.3232789360983985,1.1664397421258905,0.17777777777777778,0.270589022820217,1.0,9/93,21.49%,VEGFA;ATP6V0C;ATP6V1F;CSF1;ATP6V0A1;ATP6AP1;TCIRG1;HLA-DQB1;IL11
prerank,Herpes simplex virus 1 infection,0.23317674548545048,1.1660766369850277,0.14492753623188406,0.2696515009711278,1.0,44/498,23.53%,SRSF6;ZNF460;AKT3;ZNF316;TP53;PPP1CA;MTOR;ZNF717;PILRB;SRSF2;TYK2;SRSF5;BIRC2;CD74;EIF2AK1;B2M;EIF2AK2;STAT1;AKT1;BIRC3;ZNF621;ZNF768;IRF3;BAX;SRSF3;ZNF777;ZNF480;TAB2;PIK3CB;TNFRSF1A;PIK3CA;NECTIN1;HLA-DQB1;IFNAR1;C3;TRAF2;MAP3K7;ZNF841;BAD;ZNF420;AKT2;RHEB;SRSF1;PIK3R3
prerank,RNA degradation,-0.26839130241035764,-1.163670449181112,0.18604651162790697,0.543404040279541,1.0,17/79,17.57%,LSM1;PARN;EXOSC8;BTG1;TOB1;LSM3;DCP2;MPHOSPH6;PNPT1;HSPA9;EDC4;PFKM;NUDT16;EXOSC2;CNOT10;CNOT4;EXOSC7
prerank,Hypertrophic cardiomyopathy,0.3306026924368598,1.1539755846755169,0.22448979591836735,0.2873805872244498,1.0,11/90,18.97%,ITGA3;LMNA;ACTG1;PRKAA1;TPM1;CACNG6;PRKAB1;TPM3;TPM4;ACTB;TPM2
prerank,ABC transporters,-0.37939720323020315,-1.1519046482918651,0.24074074074074073,0.5344267173300982,1.0,6/45,26.20%,ABCB10;ABCC4;ABCB7;ABCA2;ABCB6;ABCA4
prerank,Ferroptosis,0.29751280882162656,1.1513696045730584,0.2553191489361702,0.2895739768667946,1.0,11/41,22.13%,TP53;ACSL1;ATG5;FTH1;PCBP2;ACSL4;NCOA4;SLC7A11;VDAC2;SAT2;FTL
prerank,Neuroactive ligand-receptor interaction,-0.3090429330394309,-1.1399955990487487,0.3170731707317073,0.5328152539657106,1.0,20/341,38.80%,ADORA2B;HTR1D;P2RX4;GAL;F2RL1;PARD3;LPAR2;ADM;S1PR2;P2RY6;TAC4;GABRA3;NMU;NMB;VIPR1;S1PR3;LEPR;P2RY11;P2RY2;CHRNB1
prerank,Citrate cycle (TCA cycle),0.3026842836141884,1.1396559412627372,0.2857142857142857,0.30452088160161583,1.0,9/30,23.60%,OGDH;DLD;ACO2;SDHA;PDHB;ACLY;MDH2;CS;DLST
prerank,beta-Alanine metabolism,0.37135373214333156,1.1347795512382621,0.1951219512195122,0.31004111260854844,1.0,5/30,16.09%,ALDH3A1;ABAT;ALDH3A2;ALDH1B1;HADHA
prerank,Glycerolipid metabolism,0.29002523289080456,1.1283321587042934,0.30612244897959184,0.31769726590168584,1.0,9/61,16.08%,ALDH3A2;MGLL;LPIN2;GPAT4;AKR1B1;ALDH1B1;AKR1B10;MBOAT2;DGKZ
prerank,Pertussis,0.3019510268640894,1.124440572247824,0.25,0.32239079384567415,1.0,12/76,19.87%,CALML5;MAPK1;CFL1;MAPK3;GNAI2;IRF3;CALM2;CALM1;CALM3;C3;C1S;MAPK8
prerank,Toll-like receptor signaling pathway,0.2971371091697039,1.1241307741139945,0.25,0.32112830951156046,1.0,19/104,26.68%,AKT3;MAPK1;SPP1;MAPK3;STAT1;AKT1;RAC1;IRF3;TAB2;PIK3CB;PIK3CA;MAP2K4;IFNAR1;MAP3K7;MAPK8;AKT2;PIK3R3;MAPK11;IKBKG
prerank,Glyoxylate and dicarboxylate metabolism,-0.335498359403122,-1.1198770280537473,0.36363636363636365,0.5467723521871495,1.0,7/30,17.65%,CAT;ACAT1;SHMT1;PGP;GCSH;MMUT;ACO1
prerank,Mitophagy,0.27506702220741464,1.1157380801978296,0.29545454545454547,0.33206244451218564,1.0,21/68,24.75%,ATF4;TP53;SP1;MFN2;CSNK2A2;BNIP3L;RHOT2;TAX1BP1;GABARAP;ATG5;BECN1;RPS27A;KRAS;UBB;NRAS;RRAS2;MAPK8;CSNK2A1;SQSTM1;PGAM5;USP8
prerank,Amyotrophic lateral sclerosis,0.20712886391782345,1.105569892961136,0.21875,0.3460630932143363,1.0,49/364,15.40%,TPR;ATF4;VAPB;HNRNPA2B1;RANBP2;ATP5PD;SETX;GPX2;NDUFB7;KIF5B;COX6A1;FUS;ATXN2L;COX6B1;TP53;ACTG1;RAB1A;MTOR;NDUFA4;NDUFC2;COX4I1;NUP153;UQCRB;ITPR3;PIK3C3;SDHA;MATR3;NRG4;NUP160;RAC1;GABARAP;UBQLN1;COX5A;PSMA5;NDUFB2;BECN1;PSMD9;BAX;SRSF3;UQCRC2;TANK;DERL1;NDUFS5;ATP5PB;GPX8;NDUFS2;TNFRSF1A;COX7A2;GPX3
prerank,Various types of N-glycan biosynthesis,0.31405692537963475,1.1055294214638758,0.3484848484848485,0.34435553187163415,1.0,9/39,22.02%,MAN1A2;DAD1;MGAT4B;HEXA;DDOST;RPN1;ALG13;STT3B;STT3A
prerank,Glycosaminoglycan biosynthesis,-0.268515519404499,-1.0786636055844083,0.39622641509433965,0.6217612185075921,1.0,7/53,17.81%,B4GALT7;EXTL3;HS3ST1;B4GALT1;CHST3;HS6ST2;XYLT2
prerank,Mucin type O-glycan biosynthesis,0.3626562347933165,1.0437514976336921,0.4528301886792453,0.45342788251599553,1.0,6/36,22.46%,C1GALT1;B3GNT3;GALNT2;ST3GAL1;C1GALT1C1;GALNT14
prerank,Propanoate metabolism,-0.31614634412475373,-1.0413264288832822,0.34615384615384615,0.6916493083373392,1.0,9/34,26.10%,ACAT1;EHHADH;MMUT;BCKDHA;SUCLG1;ACOX3;SUCLG2;PCCB;LDHB
prerank,IL-17 signaling pathway,0.26123214778183224,1.0351126389959306,0.3958333333333333,0.469045154213025,1.0,17/94,26.82%,MAPK1;MAPK3;GSK3B;TAB2;HSP90B1;TNFAIP3;MAPK6;TRAF2;MAP3K7;MAPK8;SRSF1;MAPK11;TAB3;HSP90AA1;JUND;IKBKG;LCN2
prerank,Spinocerebellar ataxia,0.22678145590858395,1.0340646350180822,0.43636363636363634,0.4691781514985935,1.0,36/143,30.25%,AKT3;OPA1;CIC;ATXN2L;MTOR;SP1;ITPR3;NFYA;PIK3C3;ATXN1L;PRKCA;AKT1;PSMA5;BECN1;PSMD9;PIK3CB;PRKCG;PUM2;PIK3CA;PSMD2;TRAF2;VDAC2;MAPK8;AKT2;PIK3R3;WIPI2;RBPJ;PSMA2;ATG13;ATXN10;PSMB5;PSMA7;PIK3R4;PUM1;PIK3R2;CYCS
prerank,Basal cell carcinoma,0.3138988149704304,1.0289615933164866,0.4262295081967213,0.47718468628808813,1.0,9/63,22.22%,PTCH1;TP53;DVL3;GSK3B;BAX;CTNNB1;WNT9A;DVL1;CDKN1A
prerank,C-type lectin receptor signaling pathway,0.24958320992140187,1.0278492806588009,0.46296296296296297,0.47669176536579855,1.0,24/104,27.56%,AKT3;CALML5;MAPK1;MAPK3;ITPR3;PAK1;STAT1;AKT1;KRAS;CALM2;PIK3CB;PIK3CA;NRAS;CALM1;CALM3;RRAS2;MAPK8;AKT2;PIK3R3;NFKB2;MAPK11;IKBKG;ARHGEF12;BCL10
prerank,Epstein-Barr virus infection,0.21533368728917843,1.021104956334367,0.41509433962264153,0.4884779471802987,1.0,41/202,26.68%,CDK6;NCOR2;AKT3;NEDD4;TP53;CDK2;HDAC2;TYK2;B2M;EIF2AK2;STAT1;RB1;AKT1;RAC1;HDAC1;IRF3;BAX;LYN;TAB2;PIK3CB;MYC;PIK3CA;TNFAIP3;MAP2K4;HLA-DQB1;PSMD2;IFNAR1;TRAF2;MAP3K7;CD44;MAPK8;CDKN1A;AKT2;PIK3R3;CCND1;NFKB2;RBPJ;GADD45A;SIN3A;MAPK11;IKBKG
prerank,Prion disease,0.20407100449807442,1.0116270608154356,0.4,0.5039421306134013,1.0,54/273,25.62%,ATF4;ATP5PD;NDUFB7;KIF5B;COX6A1;COX6B1;MAPK1;NDUFA4;NDUFC2;COX4I1;PRKACB;MAPK3;UQCRB;ITPR3;CSNK2A2;CREB3L2;SDHA;GSK3B;RAC1;COX5A;PSMA5;NDUFB2;PSMD9;BAX;UQCRC2;NDUFS5;ATP5PB;NDUFS2;PIK3CB;COX7A2;STIP1;PIK3CA;PRKACA;PSMD2;CREB3;UQCR10;VDAC2;MAPK8;CAV1;UQCR11;NDUFA5;NDUFC1;BAD;CSNK2A1;COX7C;UQCRQ;PIK3R3;NDUFA1;NDUFB6;TUBA1C;NDUFA13;NDUFA10;PSMA2;ATP5F1B
prerank,"Glycine, serine and threonine metabolism",-0.3296692124777478,-1.0091929995600601,0.43478260869565216,0.7526501319795241,1.0,5/40,10.95%,PGAM1;SHMT1;BPGM;PSAT1;GCSH
prerank,Circadian rhythm,0.3325695974641515,1.0049461496197214,0.5294117647058824,0.5146543807383257,1.0,6/31,13.38%,CSNK1E;SKP1;PRKAA1;CSNK1D;PRKAB1;CRY1
prerank,Pentose phosphate pathway,0.32035399309282003,1.0046219348186212,0.4,0.5130870078083032,1.0,5/30,18.25%,GPI;PGD;PFKP;ALDOA;H6PD
prerank,Oocyte meiosis,0.23983175333083437,0.9983913518160643,0.4642857142857143,0.5221039835252066,1.0,30/129,26.87%,PPP2R5E;CALML5;CDK2;PPP1CA;PPP2R1A;SKP1;YWHAZ;MAPK1;PRKACB;MAPK3;ITPR3;YWHAG;RPS6KA3;CALM2;ADCY6;ANAPC13;PRKACA;CALM1;YWHAB;CALM3;ADCY7;YWHAE;IGF1R;CDC16;ANAPC1;MAD1L1;PPP2R5C;ANAPC2;MAPK11;RPS6KA1
prerank,Necroptosis,0.2135955177412129,0.9886234758804902,0.42857142857142855,0.5372619156743303,1.0,24/159,24.13%,PYGL;CAPN1;TYK2;TRPM7;SPATA2L;BIRC2;EIF2AK2;STAT1;BIRC3;BAX;FTH1;CHMP2A;TNFRSF1A;PPIA;TNFAIP3;IFNAR1;TRAF2;VDAC2;MAPK8;GLUD1;FTL;CAPN2;SQSTM1;PGAM5
prerank,Hematopoietic cell lineage,0.29238644706038996,0.9885709262201915,0.5,0.5348826441940577,1.0,7/99,21.49%,ITGA3;CD59;CSF1;CD55;HLA-DQB1;CD44;IL11
prerank,Lysosome,0.20516858514115993,0.9816953971455312,0.46296296296296297,0.5450244609580553,1.0,23/128,20.58%,CLTB;LAPTM5;ATP6V0C;AP3B1;CTNS;SORT1;AP1S1;LIPA;CTSD;AP1G2;GNPTAB;HEXA;AP3M1;FUCA1;ATP6V0A1;CLTC;LAPTM4B;ATP6AP1;GUSB;TCIRG1;IDS;AP1B1;NPC2
prerank,p53 signaling pathway,0.25035435250917304,0.9763647127794175,0.5294117647058824,0.5525169841768448,1.0,11/73,17.63%,CDK6;TP53;CDK2;THBS1;SHISA5;PMAIP1;BAX;CDKN2A;CCNG1;ATR;IGFBP3
prerank,Basal transcription factors,-0.25298251858630566,-0.959878453929533,0.4883720930232558,0.8650536772953051,1.0,10/45,29.31%,GTF2H4;TAF5L;ERCC2;TAF6;TAF8;GTF2E2;TAF7;TAF6L;CDK7;TAF13
prerank,N-Glycan biosynthesis,0.24647508313908084,0.9321658921762022,0.639344262295082,0.643487718896771,1.0,11/50,22.02%,MAN1A2;DAD1;MGAT4B;DDOST;RPN1;MOGS;DPM3;ALG5;ALG13;STT3B;STT3A
prerank,Purine metabolism,-0.21844819917462174,-0.92654410542325,0.5897435897435898,0.9202966557557168,1.0,25/129,30.64%,PDE2A;RRM1;PNP;NME7;DGUOK;PPAT;PAPSS2;PAICS;NUDT9;NUDT16;GMPR2;NME1;PGM1;PRPS1;AMPD2;GMPS;PRPS2;IMPDH2;NME1-NME2;PAPSS1;ITPA;NME4;PGM2;ENTPD6;ENTPD4
prerank,Arrhythmogenic right ventricular cardiomyopathy,0.2617056359056551,0.9215323823835518,0.6181818181818182,0.6670991119958843,1.0,4/77,3.35%,ITGA3;LMNA;DSP;ACTG1
prerank,Amino sugar and nucleotide sugar metabolism,0.24621891346495034,0.9107682898614228,0.5531914893617021,0.6874206517852927,1.0,6/48,12.11%,GPI;GFPT1;GALK1;UXS1;HEXA;HK1
prerank,Antigen processing and presentation,-0.24121939245996027,-0.9041866225103726,0.6170212765957447,0.9443198205415799,1.0,11/78,29.44%,CREB1;TAPBP;CALR;IFI30;CTSL;HSPA5;HLA-DMA;HLA-E;CTSS;HSPA8;PSME1
prerank,Cell cycle,-0.192944888238814,-0.8999991327629494,0.6829268292682927,0.9163665243167551,1.0,26/124,16.79%,MCM2;CCNE1;CDC6;MCM6;PCNA;CDC26;ORC1;RBX1;E2F4;BUB1B;CDC25A;ANAPC4;E2F1;CCND3;ESPL1;MCM3;CDK1;PTTG1;YWHAH;E2F3;CDC45;MAD2L1;CHEK1;MCM5;CCNB1;ORC6
prerank,Tryptophan metabolism,-0.2829102901021721,-0.8986648084953832,0.5535714285714286,0.88159950328473,1.0,6/42,15.94%,CAT;ACAT1;EHHADH;ALDH9A1;DHTKD1;HADH
prerank,Arginine and proline metabolism,0.25702060642551894,0.8975342450720215,0.7560975609756098,0.7131029662647059,1.0,7/50,20.23%,PYCR1;L3HYPDH;ALDH3A2;ALDH1B1;ODC1;P4HA2;SAT2
prerank,Phagosome,0.20190024556332584,0.8951080106086757,0.7555555555555555,0.7144879947183711,1.0,17/152,18.77%,ACTG1;ATP6V0C;DYNC1H1;SCARB1;THBS1;PIK3C3;VAMP3;ATP6V1F;RAC1;HGS;ATP6V0A1;ATP6AP1;ACTB;DYNC1I2;TCIRG1;HLA-DQB1;C3
prerank,Steroid hormone biosynthesis,0.304846235857261,0.8893558984467972,0.6470588235294118,0.7260102143768784,1.0,6/61,17.88%,CYP1B1;UGT1A6;AKR1C2;AKR1C1;AKR1C3;UGT1A3
prerank,Galactose metabolism,0.2855864191384599,0.8882140703984378,0.6222222222222222,0.7253939757425067,1.0,6/31,16.61%,PFKP;GALK1;AKR1B1;HK1;AKR1B10;UGP2
prerank,Sphingolipid metabolism,-0.2651565179009943,-0.8809612842270375,0.631578947368421,0.8974138759814133,1.0,7/49,16.70%,SMPD4;PLPP3;SGPL1;SGMS2;SPHK1;ARSA;SMPD1
prerank,Cytosolic DNA-sensing pathway,-0.23960321051064107,-0.8652034445667897,0.6875,0.9000129417129897,1.0,7/63,17.91%,RIPK1;NFKBIB;POLR3GL;POLR3K;NFKBIA;POLR3A;CGAS
prerank,RNA polymerase,0.2521802193234177,0.8548183939507175,0.7358490566037735,0.7923337187888132,1.0,7/31,18.17%,POLR1D;POLR2F;POLR2H;POLR2J3;POLR2J;POLR2I;POLR2L
prerank,Fatty acid degradation,0.24784784785013186,0.8538619661323908,0.6938775510204082,0.7908048826557115,1.0,8/43,16.09%,ACAA1;ALDH3A2;ACADVL;ACAT2;ACSL1;ALDH1B1;ACSL4;HADHA
prerank,Mineral absorption,-0.23895179350508822,-0.8529279835692485,0.6666666666666666,0.8962506008652459,1.0,6/60,10.19%,STEAP1;MT1X;MT1G;MT1A;SLC30A1;MT1F
prerank,Other types of O-glycan biosynthesis,0.2372757648552629,0.8521231905682379,0.625,0.7905830580041951,1.0,9/47,23.65%,C1GALT1;MFNG;OGT;GALNT2;POMT2;C1GALT1C1;GALNT14;PLOD3;RFNG
prerank,SNARE interactions in vesicular transport,0.23522120358871257,0.8500099218633994,0.6304347826086957,0.7911203213803446,1.0,9/33,23.97%,YKT6;VAMP3;STX17;STX16;VAMP2;STX6;STX7;VAMP7;VTI1B
prerank,Th1 and Th2 cell differentiation,0.22454144557653694,0.8490454393868244,0.7547169811320755,0.7893165304048526,1.0,6/92,8.33%,NOTCH2;MAPK1;PLCG1;TYK2;MAPK3;STAT1
prerank,Fructose and mannose metabolism,-0.2771544370502458,-0.8435429405727352,0.6415094339622641,0.8844478906768604,1.0,5/33,15.63%,HK2;TIGAR;GMDS;PFKM;PMM1
prerank,Inositol phosphate metabolism,0.21056848754950921,0.8176034072788809,0.7254901960784313,0.8424416283532307,1.0,8/73,16.03%,PIK3C2A;PLCG1;MTMR4;PIK3C3;INPPL1;ITPK1;PIK3CB;PIK3CA
prerank,Ether lipid metabolism,0.2535987733182142,0.8077247932238594,0.7391304347826086,0.8517729364458198,1.0,5/49,14.83%,TMEM86B;PAFAH1B1;GDPD3;AGPS;LPCAT2
prerank,Protein export,0.24259057734462577,0.8013232323765721,0.7222222222222222,0.8589386241319943,1.0,10/23,30.88%,SPCS2;SEC11A;SEC63;SEC62;SPCS3;SRP9;SRP68;SRP14;SEC61G;SRP19
prerank,Glycosphingolipid biosynthesis,-0.2513067262530556,-0.7979278261457439,0.7959183673469388,0.9438391283448165,1.0,3/45,11.25%,FUT3;A4GALT;B4GALT1
prerank,Nicotinate and nicotinamide metabolism,0.23252854356148764,0.7731898246827726,0.7692307692307693,0.8994175930355105,1.0,4/35,15.54%,NADK;SIRT1;NNT;NAMPT
prerank,Drug metabolism,-0.19691114358442433,-0.7588656454649148,0.8958333333333334,0.9716872296106394,1.0,17/108,29.94%,NAT1;UCKL1;RRM1;NME7;CES2;NME1;UMPS;DPYD;UCK2;GMPS;IMPDH2;MGST2;GSTK1;GSTO1;NME1-NME2;ITPA;NME4
prerank,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,0.24835053086183584,0.756765390175753,0.78,0.9180949977738652,1.0,4/26,18.68%,PIGN;PIGT;GPAA1;PIGO
prerank,Biosynthesis of unsaturated fatty acids,0.22528320091994097,0.7559849898262859,0.7777777777777778,0.9147480757425509,1.0,2/27,3.15%,HSD17B4;ACAA1
prerank,RIG-I-like receptor signaling pathway,0.2042108483551942,0.7520627647327425,0.92,0.9155932237387281,1.0,16/70,33.24%,SIKE1;MAP3K1;ATG5;IRF3;TANK;TRAF2;MAP3K7;MAPK8;DDX3X;TRIM25;MAPK11;IKBKG;AZI2;ATG12;PIN1;TBK1
prerank,Cytokine-cytokine receptor interaction,0.18306208763860934,0.7363275865366083,0.9433962264150944,0.9282816387740086,1.0,11/295,22.44%,OSMR;TGFBR2;TNFRSF12A;LTBR;CSF1;IL6ST;TNFRSF1A;IFNAR1;TNFRSF18;IL11;INHBA
prerank,Peroxisome,0.17520291532563573,0.7232374202230288,0.9245283018867925,0.9366604285185268,1.0,9/82,15.73%,HSD17B4;PRDX5;ACAA1;CROT;ACSL1;PEX5;AGPS;ACSL4;PRDX1
prerank,Glycerophospholipid metabolism,0.1786138026189359,0.7109403701973118,0.9019607843137255,0.9448219034698806,1.0,10/98,16.08%,MBOAT7;ETNK1;CHKA;LPGAT1;LPIN2;GPAT4;LPCAT2;MBOAT2;PNPLA6;DGKZ
prerank,Cell adhesion molecules,0.1785338957738445,0.6804364409433094,0.9111111111111111,0.9653261023546876,1.0,20/148,36.30%,CLDN1;SDC3;PTPRF;L1CAM;ALCAM;NECTIN1;HLA-DQB1;GLG1;MPZL1;SDC1;NRCAM;CD276;PTPRM;NECTIN3;CD99;CLDN7;CDH1;CLDN9;CLDN4;CDH2
prerank,Arachidonic acid metabolism,-0.24415141042427543,-0.6796539160264615,0.8627450980392157,1.0,1.0,4/61,15.30%,ALOX5;PTGIS;PTGES2;PTGDS
prerank,Porphyrin and chlorophyll metabolism,0.210356823388108,0.6773851749199794,0.9019607843137255,0.9637906599232565,1.0,6/43,22.07%,BLVRB;UGT1A6;ALAS1;GUSB;UGT1A3;CPOX
prerank,Terpenoid backbone biosynthesis,-0.20093574562800173,-0.6655084327526789,0.9166666666666666,0.9891969435987822,1.0,6/22,24.29%,ACAT1;PDSS1;HMGCR;HMGCS1;RCE1;PMVK
prerank,Leishmaniasis,0.17590080615755024,0.6649876439814638,0.9787234042553191,0.9657541607436826,1.0,10/77,27.49%,MAPK1;MAPK3;STAT1;TAB2;HLA-DQB1;C3;MAP3K7;EEF1A1;MAPK11;IFNGR1
prerank,Inflammatory bowel disease,0.1980822723926619,0.647040057966152,0.9473684210526315,0.9708882277943052,1.0,2/65,8.33%,SMAD3;STAT1
prerank,Fatty acid elongation,-0.14895611915910054,-0.5501790539300402,1.0,0.9930299631469316,1.0,4/27,15.94%,ACAA2;HACD1;HACD3;HADH
